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Prolonged  low-flow  (ischaemic)  priapism  results  in  a progressive  alteration  of the 
microenvironment within the  corpus cavemosum with the development of hypoxia, 
acidosis and glucopenia and a reduction in the responsiveness to a-adrenergic receptor 
agonists.  The  aim  of  this  study  was  to  investigate  the  changes  in  the  corporal 
microenvironment in patients presenting with refractory low-flow priapism and then 
develop an in vitro model to investigate the effects of hypoxia, acidosis or glucopenia 
on  the  tone  of  the  rabbit  corpus  cavemosum.  The  recovery  of  smooth  muscle 
contractility following exposure to these conditions was also investigated.  Hypoxia, 
acidosis  or glucopenia  alone  or  in  combination  showed  a  sustained  and  significant 
reduction in the smooth muscle tone. This was most marked for conditions of hypoxia 
combined with glucopenia and the combination of hypoxia, acidosis and glucopenia. 
Reperfusion of tissue strips showed complete recovery of smooth muscle tone for all 
conditions  except  when  hypoxia  and  glucopenia  were  combined  or when  hypoxia, 
glucopenia and acidosis were used in combination. Incomplete recovery of tone was 
not associated with an impairment of nitrergic relaxation responses but was associated 
with  a  significant  reduction  in  tissue  ATP  concentrations  and  an  increase  in  the 
number of TUNEL-positive  nuclei.  This  indicates  that  in  the  presence  of hypoxia, 
acidosis  and  glucopenia,  failure  of conventional  a-adrenergic  agonists  in  low-flow 
priapism  is  associated  with  irreversible  smooth  muscle  cell  dysfunction  which  is 
linked to ATP depletion and smooth muscle cell death.
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16CHAPTER 1 
INTRODUCTION
1.1  Historical Background to Priapism
Priapism  is  a  rare  condition  and  is  defined  as  a  prolonged  penile  erection 
which is maintained in the absence of sexual stimulation and persists despite orgasm. 
The term is derived from Roman and Greek mythology and the mythological figure 
Priapus.  He  was thought to  be the  son of Aphrodites.  Under a  spell  cast by  Hera, 
Aphrodites gave birth to a son with an enormously and disproportionately enlarged 
phallus. Later cast out, Priapus became a symbol of the sacredness of birth and life in 
humans and the vitality of the animal and plant kingdoms. The enlarged phallus came
i t
to represent male generative power. Italian fertility cults based in Sicily in the 18  and 
19th century attributed magical therapeutic powers to an effigy of genitals displayed to 
cure or prevent disease affecting the genitals.
The  earliest  account  of the  disorder  in  the  medical  literature  is  the  citation 
entitled “Gonorrhoea, Satyriasi et Priapisme” by Petraens (1). However, over the next 
few  centuries,  reports  were  mainly  restricted  to  case  studies  and  management 
strategies for the condition. It was not until the early 20th century that Hininan through 
his extensive experience in managing this disorder attempted to classify the disease 
and suggested a rational  approach to  its management.  He  initially  classified  it into 
either  mechanical  or  nervous  types.  The  mechanical  type  was  more  common  and 
would be equivalent in its presentation to low-flow or ischaemic priapism in modem 
times.  He described this as being related to thrombosis of the veins of the corpora. 
Multiple  clinical  conditions  were  also  grouped  into  this  category  including  pelvic 
abscesses,  penile  tumours,  perineal  and  genital  injuries  and  blood  dyscrasias.  The
17second category related to intracerebral disorders affecting the erectile process such as 
syphilis,  brain  tumours,  epilepsy,  spinal  cord  injuries  (2).  Following  on  from  his 
father’s  work,  Frank  Hinman  Jr  hypothesized  that  the  vascular  stasis  due  to  a 
reduction in venous outflow was the primary reason for a failure of detumescence in 
cases of idiopathic priapism. The identification of dark viscous blood most commonly 
seen following aspiration or incision of the corpus cavemosum in patients presenting 
with the condition supported this notion (2).
These observations led to the hypothesis that ischaemia may have a role in the 
development of priapism. Hinman proposed that deoxygenated blood either due to a 
reduced oxygen tension or elevated carbon dioxide tension enhanced blood viscosity 
particularly in patients with deformed erythrocytes such as sickle cell disease (2). The 
first accounts of the histopathological changes were also proposed namely oedema of 
the trabeculae and later corporal fibrosis (2).
Although the condition still lacks a complete understanding of the underlying 
pathophysiology, what is clear is that the overall condition can be classified with each 
subtype  showing  a typical  course  of events.  These  have  developed  predominantly 
from  case  reports  and  anecdotal  reports  of clinical  cases  over  the  last  50  years. 
However,  considerable  overlap  does  exist  amongst  these  categories;  The  main 
subtypes are:
1.  Low-flow (ischaemic) priapism
2.  High-flow (non-ischaemic) priapism
3.  Recurrent stuttering priapism
18In  order to  understand  the  underlying  dysfunction,  which  characterizes  the 
condition of priapism, the physiological basis of penile erection is reviewed.
1.2  Physiology of Penile Erection
Penile erection is mediated by a spinal reflex following the central integration 
of multiple  stimuli  involving  central  neurotransmitters  as  well  as  autonomic  and 
somatic  efferents.  The  end  result  is  smooth  muscle  relaxation  of  the  corpus 
cavemosum which is essential to penile erection. The degree of smooth muscle tone 
in the penis is dependent on the balance between contractile and relaxant factors (3). 
An  imbalance  in the  normal  regulatory  mechanisms  of penile  smooth  muscle  tone 
would result in a spectrum of disorders. At one extreme increased smooth muscle tone 
as a result of a failure of smooth muscle relaxation can lead to erectile dysfunction. At 
the  other  end  persistent  smooth  muscle  relaxation  or  a  failure  of contraction  can 
present as priapism.
A normal penile erection is a complex haemodynamic event involving local, 
humoral and neural factors. The initial part of this section deals with normal penile 
anatomy  and  is  followed  by  a  review  of the  regulatory  pathways  culminating  in 
smooth muscle relaxation.
1.2.1  Anatomy of the Human Penis
The  human  penis  is  composed  of three  bodies  of erectile  tissue;  the  two 
corpora cavernosa and the corpus spongiosum. The corpus spongiosum encircles the 
urethra. Surrounding each cavernosal body is the tunica albuginea which fuses in the 
midline  to  form  an  incomplete  septum.  The  tunica  albuginea  is  a  multilayered 
structure  of  inner  circular  and  outer  longitudinal  layers  of  connective  tissue
19encompassing the paired corpora cavernosa (Figure  1). The proximal portion of each 
corpus is known as the crus and is attached to the inferior ramus of the pubic bone. 
Each crus is surrounded by the ischiocavemosus muscle. Ventral to the corpora is the 
corpus  spongiosum,  the  distal  part  of which  expands  to  form  the  glans  penis.  The 
proximal part of the corpus spongiosum is known as the bulb and is enclosed by the 
bulbospongiosus muscle. Both the ischiocavemosus and the bulbospongiosus muscles 
are important in producing the rigid phase of an erection and in ejaculation (4;5).
Figure  1:  Cross  sectional  illustration  of the  human  penis  illustrating the  anatomy of the penis.  The 
inner and outer layers of connective tissue comprising the tunica albuginea are illustrated.
Each cavernosal body is composed primarily of smooth muscle (40-50%) and 
connective tissue (45%) interspersed with endothelium, fibroblasts and neural tissue. 
Within  each  corpus  cavemosum  there  is  a  network  of  interconnected  sinusoidal 
spaces (the trabeculae).  Each sinusoidal space is surrounded by an endothelial layer,
Urethra
Outer
longitudinal
layer
Inner
circular
Emmisary
vein
Neurovascular bundle
Corpus
cavernosum
Tunica
albuginea
20which  in  turn  is  enclosed  in  bundles  of  smooth  muscle.  The  smooth  muscle  is 
separated by a fine meshwork of collagen and elastin.
Although the corpus spongiosum contains spongy erectile tissue, this does not 
provide  structure  to  the  erection.  The  smooth  muscle  is  less  abundant  and  the 
cavernous  spaces within the corpus  spongiosum are  larger in  size  compared to the 
corpus cavemosum. It is the ultimate relaxation of the trabecular smooth muscle in the 
corpus cavemosum and arteriolar smooth muscle which results in an increased blood 
flow into the cavernous spaces, which in turn causes penile engorgement and erection
(4).
The penis receives its arterial blood supply from the internal pudendal artery, 
which is a branch of the hypogastric artery arising from the internal iliac artery. The 
internal  pudendal  artery  divides  to  form  the  perineal  artery  and  the  penile  artery, 
which  in turn  gives  rise  to  the  bulbourethral,  dorsal  and  cavernosal  branches.  The 
cavernosal  arteries  enter  the  corpora  cavernosa  at  a  point  where  the  two  crura 
converge and penetrate the tunica albuginea.  The cavernosal arteries then branch to 
form spiral shaped helicine resistance vessels and it is these arteries,  which directly 
open into the cavernous sinusoidal spaces (Figure 2) (4).
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Figure 2: Scanning electron microscopic study of a cast of penile microcirculation. It shows a helicine 
artery opening directly into a lacunar space. Helicine arteries regulate the amount of blood entering into 
the lacunar spaces acting as resistance vessels. After the proper stimulus, the muscle surrounding the 
artery relaxes; increasing the blood flow and pressure delivered to the lacunar spaces.  Modified from 
(6).
The venous  drainage  system of the penis occurs  at three  levels:  superficial, 
intermediate and deep. The superficial venous system lies above the tunica albuginea 
and predominantly drains the penile skin although anastomotic branches to the deep 
dorsal vein can also  occur.  The intermediate system consists of the deep dorsal and 
circumflex veins.  The sinusoids of the corpora cavernosa drain into a system of sub 
tunical venules that coalesce on the outer surface of the cavernous tissue just beneath 
the tunica albuginea. These venules form a number of veins which traverse the tunica 
albuginea  called  the  emissary  veins  which  subsequently  drain  into  the  circumflex 
veins on the outer surface of the tunica albuginea and then into the deep dorsal vein of 
the penis (Figure 3) (5).
22Figure 3:  Scanning electron microscopic study of the venous system of the corpus. A dense plexus of 
venules, which drain the lacunar spaces, can be seen beneath the tunica albuginea. These veins coalesce 
to form the emissary veins. Arrows indicate the position of the emissary veins. Modified from (6).
1.2.2  Neuroanatomy of the Human Penis
The  penis  receives  an  autonomic  innervation  from  both  sympathetic  and 
parasympathetic  nervous  systems.  In  addition  to  this,  somatic  afferent  fibres  are 
transmitted from the penis via the dorsal nerve of the penis.
1.2.2a Sympathetic Innervation
Sympathetic  noradrenergic  fibres  emanate  from  preganglionic  cell  bodies 
within the intermediolateral grey matter of the spinal cord between T10 and T12 and 
pass  to  the  paravertebral  sympathetic  chain.  From  here  postganglionic  fibres  pass 
through  the  pelvic,  cavernous  and  pudendal  nerves to  reach  the  corpora cavernosa. 
However, some preganglionic nerve fibres pass directly through to the paravertebral 
ganglia to reach the pelvic plexi, which are situated anterolateral to the rectum.
23From  the  superior hypogastric  plexus,  the right  and  left  hypogastric  nerves 
connect to the pelvic plexus and it is from here that the main nerve supplies, via the 
cavernous  nerves  pass  to  the  penis.  In  addition,  efferent  sympathetic  fibres  travel 
within  the  pudendal  nerve  to  supply  the  ischiocavemosus  and  bulbospongiosus 
muscles, the muscles involved in the rigid phase of erection (4). The tonic release of 
noradrenaline  from  sympathetic  nerves  together  with  the  endothelins  from  the 
endothelium maintain the penis in a flaccid state (3).
1.2.2b Parasympathetic Innervation
Preganglionic  parasympathetic  fibres  derive  from the  intermediolateral  grey 
matter of the spinal cord segments S2 to S4. It is from there that preganglionic fibres 
pass within the 6 paired nervi erigentes to the pelvic plexus. The plexus receives input 
from both parasympathetic and sympathetic nervous systems  and  it is here that the 
efferent  and  afferent  neural  pathways  to  the  penis  are  integrated.  The  cavernous 
nerves, which carry the autonomic nerve supply to the penis arise here and pass to the 
penis in close proximity to the posterolateral surface of the prostate gland. They enter 
each penile crura along with the terminal branches of the pudendal vessels.
The main role of the parasympathetic nerves is to produce arterial dilatation 
and  penile  smooth  muscle  relaxation.  Parasympathetic  activity  produces  penile 
tumescence and erection by modulating the release of noradrenaline from sympathetic 
nerve terminals (7) and also by releasing  nitric oxide (NO) and several neuropeptides
(3).
241.2.2c Somatic Pathways
Afferent information from the penis is transmitted from the penile  skin and 
glans  via the  dorsal,  pudendal  and  sacral  nerves  to  the  spinal  cord.  The  pudendal 
nerve has its cell bodies located in Onuf s nucleus which lies within the spinal cord 
segments S2-S4. These fibres convey somatosensory information from the glans penis 
and penile skin to the spinal cord.
1.2.2d Central Pathways
The  hypothalamus  contains  two  key  areas  involved  in  penile  erection:  the 
medial preoptic area (MPOA) and the paraventricular nucleus (PVN) (8). The MPOA 
is  essential  for  the  recognition  of sensory  stimuli.  Neurones  within  the  PVN  are 
innervated  by  dopaminergic  neurons  arising  from  the  caudal  hypothalamus  which 
synapse  with  oxytocinergic  neurones  (9; 10).  Multiple  inputs,  such  as  audiovisual, 
cognitive, olfactory and tactile sensation, are integrated within these centres and result 
in the activation of the autonomic pathways which mediate penile erection.  Several 
neurotransmitters  have  been  implicated  in  this  process.  The  central  pro-erectile 
neurotransmitters  are  dopamine,  adrenocorticotrophic  hormone  (ACTH)  and 
oxytocin.  Those  inhibiting  penile  erection  are  5-Hydroxytryptamine  (5-HT),  y- 
aminobutyric acid (GABA), neuropeptide Y and prolactin.
1.2.3  Haemodynamics of Penile Erection
Penile  erection  is  a  haemodynamic  event,  which  has  been  divided  into  7 
separate  phases  (5).  The  overall  balance  between  contractile  and  relaxant  factors 
determines the overall degree of penile tumescence. The variation in the arterial flow 
during the phases of penile erection is illustrated in Figure 4.
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Figure 4. Blood flow and intracavemous pressure changes during the seven phases of penile erection 
and detumescence: 0, flaccid;  1, latent filling; 2, tumescent; 3, full erection; 4, rigid stage of erection; 5, 
transient stage; 6, slow detumescence; 7, fast detumescence. Modified from (5).
The physiological changes occurring in each stage are described below:
Phase 0 - Flaccid  Stage:  During this stage the arteriolar resistance  is high and the 
corporal  smooth  muscle  demonstrates  a tonic  contraction due to  a basal  release  of 
noradrenaline from sympathetic nerves and endothelins from the endothelium.  The 
penis therefore remains flaccid under resting conditions indicating that at this point 
the sympathetic system predominates.
26Phase 1 - Latent Filling Stage: A combination of centrally located stimuli and sexual 
stimulation results in corporal smooth muscle relaxation and an increase in corporal 
blood  flow.  This  is  followed  by  a  rapid  increase  in  intracavemous  pressure.  In 
addition, there is increased flow through the cavernous and pudendal arteries.
Phase 2 - Tumescent Stage: The corporal smooth muscle relaxation is followed by 
filling of the sinusoidal spaces with blood resulting in penile tumescence. The penis is 
now both expanded and elongated.
Phase  3  -  Erection  Stage:  The  engorgement  of  the  cavernous  spaces  leads  to 
compression of the sub-tunical venules. The subsequent reduction in venous outflow 
results  in  a  further  increase  of  intra-cavemous  pressure.  A  full  erection  is  now 
achieved.
Phase  4  -  Rigid  Stage  of  Erection:  Contraction  of  the  ischiocavemosus  and 
bulbospongiosus muscles leads to the rigid phase of erection. Intracavemous pressure 
is now well above systolic arterial pressure.
Phase 5 - Transient Stage: The reestablishment of sympathetic vasomotor tone leads 
to  corporal  smooth muscle  contraction and  contraction of the helicine  vessels.  The 
penis returns to the flaccid state.
Phase 6 - Detumescent Stage: Re-opening of the venous outflow channels leads to a 
reduction in intracavemous pressure.
27Phase 7 - Fast Detumescent Stage: The veno-occlusive mechanism is no longer in 
operation and arterial inflow decreases leading to flaccidity of the penis.
1.2.4  Physiology of Ejaculation
Ejaculation  involves  the  emission  of  semen  into  the  prostatic  urethra  with  the 
simultaneous closure of the bladder neck and propulsion of semen out of the urethra. 
Central control of ejaculation is likely to be at the hypothalamus and is triggered once 
sensory stimuli reach enough intensity to initiate the effector mechanism through the 
thoracic sympathetic outlets and chains (4). Contraction of the smooth muscle cells in 
the epididymes, vasa, seminal vesicles and bladder neck is via a-adrenergic receptors 
(4;5). Ejaculation can be divided into three phases (4):
Phase I: Under sympathetic control contraction of the epididymes and vasa result in 
the emission of seminal fluid into the urethra. This is followed by contraction of the 
seminal vesicles and the prostate.
Phase  II:  Closure  of the  bladder  neck  and  contraction  of the  posterior  urethra to 
prevent retrograde flow into the bladder.
Phase III: Closure of the external sphincter followed by rhythmic contraction of the 
bulbospongiosus along the urethra.
281.2.5  Pharmacology of Penile Erection 
1.2.5a Adrenoceptors in Penile Erection
Although both a and p- adrenergic receptors have been identified within the 
penis,  a-  adrenoceptors  outnumber  p  adrenoceptors  in  a  ratio  of  10:1  (11).  The  a 
adrenoceptors  are  further  subdivided  into  ai  and  012  subtypes  (12-14).  The  ai 
adrenoceptors subtypes aiA, otiB and aio have been demonstrated in human corporal 
tissue (15) with <xia  and aio receptors being the predominant ones (14; 16).
< X 2 adrenoceptors are subdivided into < X 2a, olib, & 2C  subtypes (13) and are more 
abundant on the arterioles supplying the cavemosal spaces (17).  Functional studies 
have  suggested  the  occurrence  of  postjunctional  aj  receptors  in  the  corpus 
cavemosum  (3)  and  selective  <*2  agonists  have  induced  concentration-dependent 
contraction  of  isolated  strips  of  corpus  cavemosum  (13).  Whether  these  are  of 
importance in the regulation of corporal smooth muscle tone is still unclear.
In  addition  to  this,  prejunctional  a2  receptors  may  be  involved  in  the 
modulation  of NO  release  from  autonomic  nerves.  Stimulation  of prejunctional  0 .2 
receptors inhibits NO release in horse penile resistance arteries (18).
The  effects  of  a-receptor  stimulation  have  been  investigated  using  both 
phenylephrine and noradrenaline which have been shown to be potent contractors of 
human  corpus  cavemosum  (19).  These  contractions  were  sensitive  to  the  aj 
adrenoceptor  antagonist  prazosin  and  the  non-selective  a-adrenoceptor  antagonist 
phentolamine. In vitro contractions were sensitive to inhibition by both Ca2+ channel 
antagonists  nifedipine  and  rauwolscine  (19;20).  These  studies  suggest  that  ai-
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mediated contraction results in the release of intracellular Ca  stores followed by the 
extracellular  entry  of Ca  for  the  maintenance  of tone.  Therefore  a-adrenoceptor 
stimulation  in  the  penis  results  in  smooth  muscle  contraction  and  subsequent
29detumescence of the penis. This is the basis for the use of a-adrenoceptor agonists in 
priapism  in  order  to  promote  smooth  muscle  contraction  and  subsequent  penile 
detumescence.
p-adrenergic  stimulation  appears  to  cause  relaxation  of both  corporal  and 
penile  arteriolar  vascular  smooth  muscle  (19).  Both  pi  and  p2  adrenoceptors  are 
expressed  in  the  cavemosal  smooth  muscle  (11).  Both  procaterol,  a  selective  p2 
adrenoceptor  agonist  and  the  Pi  and  P2  adrenoceptor  agonist,  isoprenaline  relaxed 
noradrenaline contracted strips of human corpus cavemosum, which were effectively 
inhibited by the p antagonist propranolol (19). These results suggest that both pi and 
P2 adrenoceptor activation causes relaxation of corporal smooth muscle. However, p 
receptors are markedly outnumbered by a receptors on cavemosal smooth muscle and 
their  functional  role  in  the  maintenance  of  smooth  muscle  tone  is  still  largely 
unknown.
1.2.5b  Modulation of Calcium Sensitivity
The  contraction  of vascular  smooth  muscle  is  regulated  by the  intracellular
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Ca  concentration  (21).  However,  the  degree  of  elevation  in  intracellular  Ca 
concentration does not always correlate with the extent of contraction (22). In vitro 
experiments  utilising  FURA-PE3  loaded  rabbit  corpus  cavemosum  strips  with 
simultaneous  measurement  of intracellular  Ca2+  concentration  and  tension  showed 
that  the  ai  adrenoceptor-mediated  contraction  results  from  an  increase  in  the 
intracellular  Ca2+  as  well  as  an  increase  in  the  Ca2+  sensitivity  of the  contractile 
apparatus  (21).  Ca2+  sensitising  pathways  involve  the  guanosine  triphosphatase 
RhoA/Rho  kinase  pathway.  The  GTP  bound  active  form  of  RhoA  stimulates  a 
downstream kinase, Rho kinase, which phosphorylates the myosin binding subunit of
30myosin  light  chain  phosphatase  to  inhibit  myosin  light  chain  phosphatase  activity 
(23).  An  alternative  pathway  involves  protein  kinase  C  potentiated  protein 
phosphatase-1  inhibitory  protein  (CPI-17)  (21).  This  protein  inhibits  myosin  light 
chain phosphatase when phosphorylated by protein kinase C. As the extent of myosin 
light chain phosphorylation depends on the balance of activities of myosin light chain 
kinase and myosin light chain phosphatase, myosin light chain phosphatase inhibition 
by  these  pathways  results  in  increased  myosin  light  chain  phosphorylation,  which 
accounts for the increased contractile response occurring at a fixed Ca2+ concentration 
(21).
1.2.5c Cholinergic Mechanisms in Penile Erection
The  rich  cholinergic  innervation  of penile  tissue  has  been  demonstrated  by 
histochemistry  (acetylcholinesterase  staining)  or  immunohistochemistry  (24-26). 
These  nerves  have  been  shown  to  express  neuronal  NO  synthase  (nNOS)  (27). 
Muscarinic receptors have been found on both the corporal  smooth muscle cell and 
the endothelium lining of the cavernous spaces in human penile tissue (28). In vitro 
studies using cultured membranes of human corpus cavemosum and endothelial cells 
suggest that human corpus  cavemosum expresses Mi,  M2,  M3  and  M4  subtypes  of 
muscarinic receptor (28). The M3 subtype appears to be the predominant receptor on 
the endothelium  (29),  whilst the M2  and M4  subtypes  are  expressed  mainly  on the 
smooth  muscle  cell.  In  vitro  experiments  demonstrate  that  acetylcholine  causes 
relaxation of smooth muscle by releasing NO from the endothelium (19;25;30) and 
other vasodilator substances which comprise the endothelium-derived hyperpolarizing 
factor  (EDHF)  via  stimulation  of  M3  receptors  (31).  Cultured  human  corpus 
cavemosum smooth muscle cells express M2 and M4 subtypes (29). It is not known as
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wide  anatomical  separation  (32-34).  Alternatively,  stimulation  of  preganglionic 
muscarinic  receptors  on  adjacent  adrenergic  terminals  may  inhibit  the  release  of 
noradrenaline (35).
1.2.5d Nitric Oxide and Penile Erection:
Nitric  oxide  (NO)  is  produced  from  the  conversion  of the  amino  acid  L- 
arginine to L-citrulline by the enzyme NO synthase (NOS). There are three isoforms 
of NOS, namely endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS 
(iNOS).  eNOS  is  expressed  in  the  endothelium  and  nNOS  in  the  postganglionic 
parasympathetic nerve fibres innervating penile smooth muscle (25;27;36). nNOS has 
also  been  demonstrated  in  preganglionic  parasympathetic  nerves  as  well  as 
preganglionic sympathetic nerves (37-39).
The term  ‘nitrergic’  applies to nerves whose transmitter function depends on 
the release of NO or to transmission mechanisms that are brought about by NO (40). 
The  nitrergic  pathway  is  now  accepted  as  the  predominant  pathway  mediating 
cavemosal smooth muscle relaxation (41).
With  regards  to  the  role  of NO  in  the  physiology  of penile  erection,  the 
primary attention is initially given to the neuronal source of NO. The liberation of NO 
into  the  erectile  tissue  from  nNOS  requires  neuronal  depolarisation resulting  from 
electrical  impulses  transmitted  neurally  in  response  to  psychogenic  and  reflexive 
erogenous stimuli that converge upon nNOS containing efferent nerve fibres coursing 
within the corporal bodies (42). Acetylcholine as well as other neurotransmitters such 
as substance P and bradykinin stimulates NO release from endothelial sources in the 
penis  (43;44).  These  neurotransmitters  exert  their  effects  by  inducing  a  transient
32increase of calcium entry into endothelial cells which stimulates NO production by 
eNOS. Acute increases in ‘shear stress’  which is the term used to describe pressure 
forces exerted on endothelial cells by the flow of blood over them, act to drive rapid 
but limited amounts of NO release by similar biochemical mechanisms (45;46). The 
release of NO from the nitrergic nerves and endothelium ultimately results in smooth 
muscle relaxation.  NO  activates the  intracellular enzyme  soluble  guanylate  cyclase 
(sGC)  which  increases  intracellular  cGMP  concentrations.  The  resulting  smooth 
muscle  relaxation  is  thought  to  involve  several  intracellular  mechanisms.  These 
include the following:
1.  cGMP may inhibit the L-type Ca2+ channel and reduce the influx of Ca2+ into 
the cell (47)
2.  the activation of a cGMP-dependent protein kinase may subsequently mediate 
several events in the cascade including
•  inhibition of voltage-gated Ca2+ channels (48)
•  activation of Ca2+-sensitive K+ channels resulting in hyperpolarisation of the 
cell membrane (49)
•  activation of the Na+-Ca2+ exchanger (50)
•  activation of membrane bound Ca2+ATPase (51)
•  inhibition of the IP3 receptor on the sarcoplasmic reticulum (52)
•  inhibition  of the  IP3  receptor  on  the  sarcoplasmic  reticulum  membrane  by 
phosphorylating  IP3  receptor  related  regulatory  proteins  or  IP3  receptor 
associated cGMP kinase substrate (53)
•  binding  to  PIP2  phosphatidyl  inositol  4,  5  bisphosphate  and  inhibiting 
production of IP3 (54)
•  sensitisation of myofilaments to intracellular Ca  by Rho-kinase is involved 
in maintaining smooth muscle contraction. This is modulated by Rho A/cGMP 
interaction (55)
331.2.5e Endogenous Modulators of Penile Erection
Various other neurotransmitters have been identified in the corpus cavemosum 
but  the  effects  are  predominantly  modulatory  as  opposed  to  having  significant 
relaxant or contractile effects. These are mentioned briefly:
Vasoactive  intestinal  polypeptide  (VIP):  VIP-immunoreactivity  has  been 
demonstrated in human penile erectile tissue (56). Nerves containing VIP also contain 
immunoreactivity  to  NOS  and  this  colocalization  of  NOS  and  VIP  has  been 
demonstrated  in  both  humans  and  animals  (57;58).  Although  intracavemosal 
administration of VIP has been shown to cause tumescence in some individuals (59), 
it has  been  difficult  to  convincingly  demonstrate  that  VIP  released  from  nerves  is 
responsible for the relaxation of penile smooth muscle in vitro or in vivo (41). Studies 
utilising rabbit corpus cavemosum showed that a VIP antagonist inhibited electrically 
induced contractions suggesting that VIP was released from nerves during stimulation 
and concluded that the mechanism of relaxation was dependent on prostanoids and 
involved the generation of NO (60).
Histamine: The role of histamine in penile erection has received very little attention 
and is thus poorly understood. Three types of histamine receptor have been described, 
Hi, H2 and H3. The principal receptor in corpus cavemosum smooth muscle is the Hi 
subtype (61). There have been very few studies which have investigated the action of 
histamine on isolated corpus cavemosum. These studies have also been contradictory. 
One study supports the contractile role of Hi receptor activation using isolated rabbit 
corpus cavemosum (61).  However, a study utilising an in vitro preparation of human 
corpus  cavemosum  found  that  histamine  (concentration  3-100pg)  produced  a  dose
34dependent relaxation (62). Furthermore, an intracavemosal injection of histamine was 
shown to produce a penile erection in humans which is shorter in duration compared 
to papaverine use (62).
5-Hydroxytryptamine  (5-HT,  serotonin):  The  use  of selective  5-HT  agonists  on 
isolated strips of rabbit corpus cavemosum failed to induce smooth muscle relaxation 
in one study (63). A further study utilising human corpus cavemosum concluded that 
peripherally  5-HT  may  have  a  physiological  role  in  the  control  of  penile 
detumescence  and maintenance  of flaccidity.  Further  studies  utilising rabbit corpus 
cavemosum demonstrated a dual  response of contraction mediated by type  1  and  2  
receptor subtypes and relaxation mediated by type 4 receptor subtypes (64). Therefore 
the role of peripheral 5-HT is still uncertain.
Purinergic mechanisms:  The role of purines such as ATP and adenosine in penile 
erection is not fully established, although both appear to lead to relaxation of strips of 
rabbit corpus cavemosum and canine penile artery pre-contracted with noradrenaline 
(65). Further work is required to clarify their role in the control of corporal smooth 
muscle tone.
EDHF:  The  relaxation  of  vascular  tissue  evoked  by  acetylcholine  and  other 
neurohumeral substances are mediated by endothelium-dependent mechanisms which 
involve NO  as  well  as  other endothelium-derived relaxing  factors  (6 6 ).  Studies  on 
vascular  tissue  with  blockade  of  the  L-arginine-NO  pathway  by  inhibiting  NO 
synthase  and  the  prostaglandin  pathway  by  cyclooxygenase  inhibition  have 
demonstrated  that  endothelium-dependent  relaxations  still  occur and  are  associated
35with hyperpolarisation (67). The alternative EDHFs involved in relaxation pathways 
may be related to products of arachidonic acid metabolism or metabolites of P-450 
(67).  EDHF  is  reported  to  be  an  important contributor to  vasodilation  in coronary 
arteries (6 8 ). EDHF contributes to smooth muscle relaxation during penile erection. It 
has been proposed that  EDHF  has  an important role  in the  endothelium-dependent 
relaxation  of human  penile  resistance  arteries  as  opposed  to  the  trabecular  smooth 
muscle in the corpus cavemosum (31).
Endothelins:  Endothelins are 21  amino-acid polypeptides,  which are produced by 
all  endothelial  cells.  Endothelin-1  is  the  only  subtype  produced  by  vascular 
endothelial cells and causes potent contraction of all types of vascular smooth muscle, 
including corporal smooth muscle (69). Endothelin-2 and endothelin-3 are less potent 
peptides.
Endothelin-1  is not stored in discrete granules but synthesized directly from 
mRNA  in  response  to  stimuli  such  as  hypoxia,  ischaemia,  catecholamines, 
angiotensin II, thrombin or shear stress.
Receptors for endothelins namely ETa and ETb have been demonstrated on 
the  endothelium  and  smooth  muscle  of blood  vessels,  including  those  of human 
erectile tissue (70). ETb receptors are mainly expressed on the endothelial cells, whilst 
the  ETa  receptors  have  been  localised  to  the  endothelium  lining  the  cavemosal 
lacunar spaces in the penis (71). ETa receptors mediate the contractile response of the 
endothelium  (72)  while  ETb  mediates  the  endothelium  dependent  vasodilator 
response possibly through the action of ET-3 and local NO release (73).
ET-1  has  been  shown to potently induce  long  lasting  contractions in penile 
corpus  cavemosum  (69;70;74).  Therefore  the  main  role  of  endothelins  in  penile
36smooth  muscle  physiology  is  to  sustain  smooth  muscle  tone  and  maintain  penile 
detumescence (75).
Prostaglandins:  Prostaglandins  form  a  heterogeneous  group  of  substances  with 
diverse  physiological  effects.  It  has  been  known  for  some  time  that  exogenous 
prostaglandin (PGEi) application results in cavemosal smooth muscle relaxation and 
indeed it has been the  mainstay  of treatment for men with erectile  dysfunction for 
some  time  (76).  More  recently  researchers  have  tried  to  focus  on  the  possible 
physiological and pathophysiological role for prostaglandins in the penile vasculature. 
Shear stress or changes in oxygen tension can result in stimulation of the endothelium 
and activation  of phospholipase  A2  and/or phospholipase  C,  which  in turn  liberate 
arachidonic acid from membrane-bound phospholipids in vascular endothelial cells. 
Arachidonic acid is converted to PGH2 by PGH synthase or cyclo-oxygenase. There 
are  two  subtypes  of this  enzyme,  namely  the  constitutive  (COX  1)  and  inducible 
forms (COX 2). In turn, PGH2 is acted upon by a specific endoperoxidase leading to 
the  formation  of the  corresponding  prostanoid  of which  PGF2a,  thromboxane  A2 
(TXA2), PGI2 (prostacyclin), PGE2 and PGD2 are the primary active metabolites.  In 
addition, arachidonic acid may be converted into leukotrienes via the action of lipo- 
oxygenases. The action and role of leukotrienes in the control of corporal muscle tone 
is unknown.
Pharmacological studies in other vascular beds have enabled the classification of 
prostanoid  receptors  on  functional  characteristics.  Hence  PGD2  mainly  acts  on  a 
specific G-protein coupled receptor termed the DP receptor, whilst PGE2, PGF2a and 
TXA2 act via specific receptors, namely EP, FP and TP. Recently, the EP receptor has 
been further typed into 6  different subtypes, PGE 1-6. Receptor mRNA corresponding
37to EP2,  EP3I,  EP3II  and TP  subtypes have been isolated from both human corpus 
cavemosal  tissue  and  cultured  human  cavemosal  smooth  muscle  cells  (77).  The 
effects of a specific PG appear to not only depend upon the specific tissue studied but 
also the distribution of the various receptor subtypes within that tissue. Furthermore, 
there is also a considerable degree of receptor cross specificity in all vascular smooth 
muscles, including the penis.
The overall contribution of prostanoids in the regulation of penile erection is 
complex  and  not  completely  understood.  However,  endogenous  and  exogenous 
prostanoids regulate penile smooth muscle contraction via specific receptors. The TP 
receptors mediate  smooth muscle  contraction and the  EP  and  IP  receptors  mediate 
smooth muscle relaxation (78).
1.2.5 Mechanisms Involved in Penile Smooth Muscle Contraction
Contraction of human penile arteries and trabecular smooth muscle is largely 
mediated by the  stimulation of ai  adrenergic receptors by circulating noradrenaline 
(14;35) or noradrenaline release from autonomic nerves (35) as well as endothelins 
from endothelium (79).
Stimulation of ai adrenoceptors activates G protein-coupled phospholipase C. 
Once activated phospholipase C converts inositol 4,5 bisphosphate (IP2) into inositol
1.4.5  triphosphate  (IP3)  and  diacylglycerol.  IP3  binds  to  its  receptor  on  the 
sarcoplasmic  reticulum  releasing  Ca2+  into  the  cytosol.  Although  vascular  smooth 
muscle can utilise extracellular Ca2+ which enters via voltage gated L-type channels, 
IP3  -dependent  Ca2+  release  from  internal  stores  is  predominantly  responsible  for 
smooth  muscle  contraction  in  the  corpus  cavemosum.  The  contractile  process 
involves the binding of calcium to calmodulin which then activates myosin light chainkinase (MLCK). The activated MLCK catalyses the phosphorylation of the regulatory 
light  chain  subunits  of myosin  (MLC20).  Phosphorylated  MLC20  activates  myosin 
ATPase triggering myosin heads to form cross bridges with actin filaments resulting 
in smooth muscle contraction (22;80).
1.2.6  Role of Oxygen and pH in Regulation of Penile Smooth Muscle Tone
The penile arterial  inflow determines oxygen tension and the erectile tissue in 
the penis demonstrates a situation whereby the oxygen tension changes with function. 
During  the  flaccid  state  the  cavernous  tissue  oxygen  tension  is  similar  to  that  of 
venous  blood  which  is  approximately  20-40mmHg  (81 ;82).  During  erection  the 
increased arterial blood in the sinusoidal  spaces increases the pC>2 to approximately 
lOOmmHg (82). The synthesis of NO by NOS requires both L-arginine and oxygen as 
substrates. The variation in p0 2  during a penile erection has been proposed to regulate 
the synthesis of NO (81-83). Therefore at the relatively low p0 2  levels which occur 
during the flaccid state, the basal levels of NO are low (82). As cavernous levels of O2 
increase following vasodilatation in response to sexual stimulation, increased levels of 
NO are synthesised with estimates of approximately 50-60mmHg O2 required in order 
for NO synthase to reach full activity (81). In addition to reduced NO synthesis at low 
oxygen  tension,  the  formation  of  PGE2  is  also  impaired  and  contributes  to  the 
maintenance of penile flaccidity and detumescence (84).
391.3  Priapism and its Classification
Priapism can be subdivided into three main subheadings; low-flow 
(ischaemic), high-flow (non-ischaemic) and stuttering (recurrent) (85).  Each group 
has several underlying aetiological factors which are described below.
1.3.1  Low-flow (Ischaemic) Priapism
This is the most common subtype of priapism (8 6 ). Prolonged penile erection 
results  in  the  stasis  of corporal  blood  in  a  closed  compartment.  This  results  in  a 
progressive  alteration  of  the  tissue  microenvironment  consistent  with  stagnant 
ischaemia (87;88).  This  is regarded as  an acute  medical  emergency  but  in practice 
medical attention is often delayed (86;89;90).
During this condition, there  is  impairment in the outflow of blood from the 
corpus  cavemosum.  Eventually  this  results  in  a  failure  of  replenishment  of the 
cavernous  spaces  by  arterial  blood.  Approximately  50-70  millilitres  of blood  are 
trapped  within  the  cavemosal  space.  The  venoocclusive  mechanism  remains 
compressed and there is very little replenishment by arterial blood.  As the duration of 
this blood stasis increases, the extracellular milieu becomes increasingly acidotic and 
hypoxic (91).  The degree of hypoxia and acidosis in corporal blood aspirates is one 
method utilised to differentiate between low-flow and high-flow priapism (87;92).
1.3.1a Aetiology of Low-flow Priapism
Idiopathic: Approximately 30% of cases are idiopathic (86;93)
Hypercellular haematological disorders: Haematological conditions which result in 
blood  hyperviscosity  may  induce  priapism.  These  include  leukaemia  (commonest 
association  with  chronic  granulocytic  leukaemia)  (94),  thalasaemia  (95),
40polycythaemia,  fat  emboli  and  Fabry’s  disease.  Total  parental  nutrition  which 
contains  20%  fat  emulsion  may  result  in blood  hypercoaguability  (96).  By  far the 
commonest group of patients suffering from low-flow priapism are those with sickle 
cell  anaemia.  The  most  commonly  affected  are  those  with  the  homozygous  form. 
Between 38-42% of men with sickle cell disease have at least one episode of priapism 
in their lifetime.  Sickle cell crises are associated with red cell adhesion followed by 
venoocclusion in the penis. The subsequent failure of blood to drain from the penis is 
manifested as prolonged priapism (97).
Iatrogenic:  The  most  common  association  is  with  antipsychotics  (chlorpramazine, 
clozapine),  antihypertensives  (hydralazine,  prazosin,  guanethidine)  and  oral 
coumarins.  The  mechanism  is  considered  secondary  to  a-adrenergic  blockade  (98) 
Intracavemosal  agents utilised in erectile  dysfunction and directly  instilled  into the 
corpora (e.g.  papaverine, prostaglandin Ei, phentolamine)  are commonly associated 
with low-flow priapism and account for 0.5-6% of cases (89). Drugs which have the 
following pharmacological effects may also be associated with priapism due to either 
a peripheral or centrally mediated action:
1.  a adrenergic blockers
2 .  serotoninergic agonist
3.  dopamine agonist
4.  parasympathetic agonist
Malignancy:  Various  metastasic  lesions  are  associated  with  priapism.  Again 
metastatic  deposits  result  in  venoocclusion  and  the  subsequent  development  of
41priapism. Those reported include prostate carcinoma (99), bladder cancer (100; 101), 
urethral metastases (1 0 2 ).
Neurological: Although several neurological conditions are associated with the onset 
of priapism the underlying mechanism is not entirely clear. Examples of neurological 
disorders include cauda equina syndrome, spinal cord lesions and spinal stenosis. One 
suggestion is that neurological conditions may result in the potentiation of erectogenic 
neurotransmitters from the parasympathetic system or reduce the tonic discharge from 
the sympathetic neurones (103).
Others:  Other rare  causes  which have  been reported  include the  systemic  diseases 
amyloidosis and rabies (104; 105).
1.3.1b Clinical Presentation of Low-flow Priapism
Patients  presenting  with  low-flow priapism  commonly present  as  a delayed 
medical emergency.  Clinically the patients describe a prolonged painful  erection in 
excess of several hours. There is a failure of detumescence despite initial conservative 
techniques  employed  by  the patients which  include  ejaculation,  cold  baths  and the 
application  of ice  directly  onto  the  erect  penis.  Failure  of these  measures  and  the 
increasing  distress  attributed  to  the  pain,  leads  one  to  seek  appropriate  medical 
intervention (89; 104).
Although a large number of these cases are idiopathic in nature, a number of 
predisposing conditions have been reported (see section 1.3.1a). Classically the penis 
is erect and may show signs of oedema. Patients are distressed and anxious (89;97).
421.3.1c Medical Management of Low-flow Priapism
The  initial  management  involves  the  administration  of  analgesia.  As  the 
duration of the erection increases, the tissue becomes increasingly more hypoxic and 
acidotic  which  results  in  painful  stimuli  via  nociceptors  in  the  penis  and  opioid 
analgesia is often required (8 6 ).
Once  adequate  pain  relief  has  been  administered,  aspiration  of  stagnant 
corporal  blood  is  performed.  Using  a  large  gauge  needle  and  local  anaesthesia, 
corporal  blood  is  aspirated  by  inserting  the  needle  directly  into  the  corpus 
cavemosum.  The  blood  appears  deoxygenated  and  viscous.  In  some  instances  this 
may  be  adequate  in  itself to  resolve  the  problem,  venoocclusion  is  successfully 
reversed and reperfusion allows penile detumescence (85;87). The aspirated blood is 
sent for biochemical analysis in order to determine the pC>2 and pH of the aspirated 
blood and this helps to verify that this is indeed a low-flow priapism as opposed to a 
high-flow priapism (85;87;92).  However this  simple procedure may not completely 
resolve the problem and additional measures are required.
The  next  step  involves  the  instillation  of a-adrenergic  agonists  to  induce 
contraction of the corpus cavemosum and the helicine arteries in order to reduce the 
volume  of stagnated  blood  and  relieve  the  pressure  on  the  subtunical  venules  and 
ultimately  lead  to  detumescence.  Despite  the  uncertainty  in  the  initiating  events 
leading to low-flow priapism, the cavemosal smooth muscle may still fail to contract 
due to the metabolic  alteration in the  immediate microenvironment of the  corporal 
smooth muscle.
The  most common  agent utilised  is the  a-adrenergic  agonist phenylephrine 
(92). Careful monitoring of the patient’s blood pressure is required as the adrenergic 
effects of the drug on the systemic circulation can lead to systemic hypertension (92).
43One method used to minimise this is the use of a tourniquet around the base of the 
penis  in  order  to  reduce  the  systemic  absorption.  Alternative  a  adrenergic  agents 
which have successfully been utilised include epinephrine and norepinephrine  (92). 
Oral terbutaline has also  been reported to be  successful  (106; 107)  although it does 
also have P2 agonist effects and minor pi activity (85).
1.3.Id Alternative Pharmacotherapies for Low-flow Priapism
A combination of cavemosal blood aspiration and instillation of phenylephrine 
alone is successful  in a large number of cases, particularly those presenting after a 
short period of priapism. However, alternative medical treatments have been utilised 
in those patients who fail to respond to these measures:
Methylene Blue: Methylene blue is a compound with several biological effects. It is a 
well  known  inhibitor  of  soluble  guanylate  cyclase  (sGC)  (108).  By  inhibiting 
intracellular  sGC,  and  therefore  reducing  cGMP  levels,  cavemosal  smooth  muscle 
tone is increased. The use of methylene blue has been limited to anecdotal reports and 
small series (109-111).
Etilefrine: This compound is an a-adrenergic agonist which has the advantage of oral 
administration as  well  as  intracavemous  use.  It  is  commonly utilised  in  sickle  cell 
patients. Although not widely used at present, there have been successful reports in 
the literature when used sickle cell patients (112-114).
Intracorporal thrombolytic agents: Failure of conventional aspiration and drainage 
techniques  has  led  to  some  investigators  utilizing  thrombolytic  agents  such  as
44streptokinase  in  order to  allow  reperfusion  of the  erectile  tissue  (115).  Again  this 
technique  has  only  been  described  in  a  single  case  report  and  does  not  have 
widespread acceptance as a therapeutic option (85).
1.3.1e Surgical Management of Low-flow Priapism
Surgical intervention has not changed significantly over time. The underlying 
physiological basis of surgical interventions is to divert ischaemic corporal blood into 
the venous  system by developing a new channel  of blood flow.  The  main surgical 
procedures which have been utilised are listed in Table 1  and then described below.
Year Technique
1964 Quackels procedure
1964 Grayhack procedure
1975 Ebbehoj procedure
1976 Winter Shunt
1976 Barry procedure
1981 AI Ghorab procedure
Table  1.  Chronological  development  of  surgical 
procedures utilised in low-flow priapism.
Quackels  procedure:  This  procedure  was  first  described  in  1964  (116).  The 
procedure involves the formation of a shunt between the cavemosal and spongiosal 
systems and can be performed by using the proximal part of the corpus spongiosum 
where  1cm windows  of tissue  are  removed.  Once the  flow of oxygenated blood  is 
established the  openings  in  each  body  are  anastomosed  using  absorbable  5-0  PDS
45sutures.  If the  intracavemosal  pressure  falls below 40mmHg after  10-15  minutes 
then  the  procedure  can  be  deemed  successful.  However,  the  procedure  can  be 
performed  bilaterally  if  there  is  failure  of  detumescence  following  a  unilateral 
procedure.
Saphenous  vein  -   corpus  cavemosum  shunt:  This  procedure  was  described  by 
Grayhack in 1964 (117). In this procedure the saphenous vein is isolated and exposed 
for approximately  10cm. The proximal aspect is detached so that it is long enough to 
reach the penis.  An  ellipse  of tunica  is  excised  and  an  end  to  side  anastomosis  is 
created after irrigating the corpus cavemosum until oxygenated blood is obtained.
Winter Shunt and Ebbehoj  Procedure: This is the simplest shunt formed between 
the corpus spongiosum and the corpus cavemosum initially described by Ebbehoj  in
1975  (118)  and  later modified by Winter in  1976  (119).  A narrow blade  scalpel  is 
inserted  into  the  glans  dorsal  to  the  urethral  meatus  into  the  corpus  cavemosum. 
Multiple incisions are made through the same entry site by rotating the scalpel blade 
90°. The overlying glans is then closed using sutures.  In contrast Winters procedure 
uses a Trucut biopsy needle to remove cores of tunica albuginea to create fistulous 
communications.  Several  passes  may  be  required  before  successful  detumescence 
occurs.
Cavernoso-dorsal vein shunt (Barry procedure): This procedure was described in
1976  and  involves  a 4cm  skin  incision  at the  penile  base.  The  superficial  or deep 
dorsal vein is identified and mobilized. Ligation of the distal aspect is followed by an
46anastomosis of the proximal vein to the corpus cavemosum after spatulation. The size 
of the vein has meant that the procedure has not been as successful as expected.
AI  Ghorab  procedure:  This  procedure  was  first  described  in  1981  (120).  The 
procedure allows the formation of a larger shunt. A 2cm dorsal semi circular incision 
of the glans at the coronal level exposes the distal corpora.  A further circular core of 
tissue which is 5mm in diameter is excised from each corpora to create a cavernous- 
glandular  shunt.  The  glans  is  then  resutured  to  the  penis  after  the  penis  has  been 
squeezed until oxygenated blood is seen to flow.
Despite the use of these surgical procedures, approximately 50% of patients 
develop erectile dysfunction following successful detumescence (8 6 ). If the insertion 
of a penile prosthesis is required in the future, placement is very difficult due to the 
presence of significant corporal fibrosis (1 2 1 ).
1.3.2  High-Flow Priapism
1.3.2a Aetiology of High-Flow Priapism
Although this is less common compared to low-flow priapism, it is usually a 
consequence of perineal trauma (122; 123).  It commonly occurs following traumatic 
injuries  such  as  straddle-type  injuries  where  the  cavemosal  artery  is  compressed 
against the pubic bone. The injury is not realized until several hours or days following 
the trauma have elapsed and unrestricted arterial flow enters the cavernous space. A 
variable  degree  of tumescence  occurs  depending  on  the  size  and  location  of the 
arterial defect and the degree of venous drainage (122). Intracavemous injections can 
also  result  in the  formation  of a  cavemosal  artery-corporal  fistula  and  subsequent
47high-flow priapism (87; 123). Rarer causes have also been reported such as sickle cell 
disease (124), cavemosal artery pseudoaneurysms (125), Fabry’s disease (126).
1.3.2b Clinical Presentation of High-Flow Priapism
This  condition  has  a  lower  incidence  than  low-flow  priapism.  One  of the 
differentiating features between high-flow and low-flow types is the increased arterial 
blood flow which  occurs  in high-flow priapism  as  shown by  Doppler  studies.  The 
blood is well  oxygenated and the risk of ischaemic damage  with eventual  corporal 
fibrosis and impotence is low (85; 127). Potency is reported to be preserved in 77%- 
8 6 %  of  patients  with  long  term  follow  up  (122; 127).  However,  diagnosing  the 
condition is of paramount importance, particularly differentiating the condition from 
the  more  serious  low-flow  priapism.  Although  corporal  blood  aspiration  here  will 
generally reveal the presence of oxygenated corporal blood, on occasions this may be 
misleading. By inserting a needle into the corpus cavemosum of a low-flow priapism, 
an  iatrogenic  shunt  can  be  created  and  erroneously  convert  a  previous  low-flow 
priapism which has a poorly oxygenated and acidotic microenvironment  into a high- 
flow priapism as diagnosed on Doppler studies. Although the blood parameters may 
improve slightly the corpus cavemosum smooth muscle is still exposed to a hypoxic 
and  acidotic  microenvironment.  Therefore  a  thorough  history  of  each  condition 
should  be  ascertained.  The  investigation  of choice  is  a  Doppler  ultrasound.  This 
would help differentiate high velocity corporal blood flow as would occur in high- 
flow priapism from stagnant blood flow which occurs in low-flow priapism.
481.3.2c Management of High-Flow Priapism
Medical  management  generally  does  not  have  a  role  in  high-flow priapism 
although  some  conservative  methods  employed  have  been  reported  to  lead  to 
successful detumescence.  These involve the use of ice packs and observation (127). 
The use of methylene blue by intracavemosal injection has been reported to achieve 
partial detumescence (128). By using contrast injected into the systemic arterial tree, 
images  of the  internal  iliac  vessels  and  the  corporal  vessels  can  be  evaluated  as 
illustrated in Figure 5. Superselective embolisation can then be utilised using material 
such  as  gelfoam  which  is  absorbable  or  metallic  coils  (129-132).  Although 
spontaneous resolution can occur after observation,  immediate  embolisation  is both 
successful and avoids the risk of long term venous leakage (129).  In the presence of 
fistulae at the base of the corpora, duplex ultrasound guided compression can also be 
successful  in  reversing  the  high-flow  priapism.  Open  arterial  ligation  using 
intraoperative  ultrasound  techniques  has  also  been  described  (133).
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Figure 5. Arteriogram illustrating traumatic fistula in a patient with high-flow priapism (Illustration
courtesy of Mr D.J. Ralph and reproduced with permission)
491.3.3  Stuttering Priapism
1.3.3a Aetiology of Stuttering Priapism
This condition is most prevalent in patients with sickle cell anaemia although 
idiopathic stuttering priapism  is now also increasingly recognised (98).  There is no 
proven aetiology and the condition is characterised by having  features  of low-flow 
priapism  with  a  recurrent  nature  (98).  As  with  low-flow  priapism  there  is  an 
underlying alteration in the balance of relaxation and contraction within the corporal 
smooth  muscle  which  is  weighted  heavily  in  favour  of  relaxation  resulting  in 
prolonged penile erections which are generally self limiting (98).
1.3.3b Clinical Presentation of Stuttering Priapism:
This condition presents as recurrent episodes  of prolonged painful  erections 
which  are  venoocclusive  in  nature.  Despite  the  frequency  and  duration,  they 
spontaneously resolve although medical intervention is required if there is a failure of 
spontaneous  resolution  (98).  The  majority  of  patients  report  recurrent  painful 
nocturnal  erections which can last for several hours in duration.  Symptoms of pain 
indicate that the corporal blood is becoming increasingly hypoxia and acidotic with 
the  subsequent  stimulation  of  nociceptors  in  the  cavernous  tissue.  Although 
previously  interpreted  as  probably  being  physiological  nocturnal  erections  in  poor 
sleepers,  the  presence  of the  problem  in  individuals  without  warning  and  lasting 
several days with spontaneous resolution shows that this condition is distinct (98).
1.3.3c Medical Management of Stuttering Priapism
Management  using  rehydration  and  exchange  transfusion  appears  to  be 
sufficient in a vast majority of cases where this is a manifestation sickle cell disease.
50Hormone  analogues  and  subcapsular  orchidectomy  attempt  to  abolish  erectile 
function altogether by reducing testosterone circulation which then reduces the levels 
of NO synthase in nitrergic neurones (134). As the understanding of this condition is 
limited the therapeutic options tried thus far include:
Digoxin This is a cardiac glycoside and chronic digoxin administration is associated 
with erectile dysfunction (135).  Digoxin inhibits the smooth muscle membrane Na+- 
K -ATPase (136) which prevents the efflux of Ca  from the smooth muscle cell and 
increases the intracellular Ca  level.  Smooth muscle contraction occurs which then 
results in penile detumescence. Whether there is a significant role in priapism is still 
unclear.  However,  an  in  vitro  study  showed  that  digoxin  impairs  NO-mediated 
smooth muscle relaxation (135).
Procyclidine:  This is a muscarinic antagonist most commonly used in the treatment 
of drug-induced extra pyramidal disorders and Parkinson’s disease.  It has also been 
used  as  a  first-line  treatment  in  stuttering  priapism  at  a  dose  of 2.5mg  with  very 
limited  success.  The precise mechanism of action is  unknown with  only  anecdotal 
reports of success existing.
Cyproterone  acetate:  Cyproterone  acetate  has  a  strong  gonadotropin-inhibiting 
effect and has a well established clinical use as an anti-androgen for the treatment of 
hyperandrogenic  disorders  such  as  hirsutism,  acne  and  seborrhea  in  women. 
Cyproterone acetate is also used in the treatment of prostate cancer and hypersexuality 
disorders. The administration of cyproterone acetate to young males results in a 50% 
reduction in the plasma levels of FSH and LH together with a 75% reduction in the
51plasma  levels  of  testosterone.  The  effects  are  mediated  by  the  inhibition  of 
testosterone  production  and  direct  anti-androgen  action.  Gonadotropin  releasing 
hormone analogues have been used with success in treating recurrent priapism (134). 
In this series the frequency of priapism episodes was reduced and libido and sexual 
function was preserved (134).
Stilboestrol:  Although  most  commonly  utilized  in  sickle  cell  patients  who  suffer 
from repeated episodes of priapism, those patients with idiopathic stuttering priapism 
who can not tolerate the alternative pharmacotherapies can be successfully controlled 
on  stilboestrol.  A  double  blind placebo  controlled  crossover  study  found that  5mg 
daily was better than placebo in preventing attacks in patients with sickle cell disease
(137).
Pseudoephedrine: More commonly used as an oral decongestant, pseudoephedrine is 
often used as a first line treatment in stuttering priapism. Pseudoephedrine acts on p2 
receptors  in  bronchial  smooth  muscle to  cause  relaxation  and  via the  a-adrenergic 
receptors/cAMP pathway in the respiratory mucosa to produce vasoconstriction. The 
effects on corporal smooth muscle have not been investigated although it is likely that 
smooth muscle contraction in the corpus cavemosum is mediated by the a adrenergic 
receptors.
Phosphodiesterase  type  5  (PDE5)  inhibitors:  This  is  a novel  treatment option  in 
cases of idiopathic stuttering priapism (138). Studies utilizing rat myocytes incubated 
with the PDE5 inhibitor, sildenafil, have found an up-regulation of the enzyme PDE5
(138)  suggesting that  in  stuttering priapism a reduced level  of PDE5  in the corpus
52cavemosum  may  potentiate  the  intracellular  action  of NO  and  prolong  the  penile 
erection.  However  it  is  debatable  whether  after  the  initial  NO-mediated  corpus 
cavemosum smooth muscle relaxation, impaired smooth muscle contraction is due to 
NO  or  due  to  the  changes  in  the  corpus  cavemosum  smooth  muscle 
microenvironment.
1.3.3d Surgical Management of Stuttering Priapism
Drug Delivery Systems:  Drug delivery systems were first described in  1987 (139). 
This technique involves the use of a drug delivery system positioned into a dependent 
part  of the  scrotum.  A  cannula  is  inserted  into  the  lateral  aspect  of the  corpus 
cavemosum  and  sutured  to  the  tunica  with  a  non-absorbable  suture.  Either 
phenylephrine  (140)  or  etilefrine  (141)  is  instilled  into  the  corpus  cavemosum  by 
squeezing a pump and promoting  detumescence.
Penile  Prosthesis:  Individuals  who  fail  to  control  their  symptoms  by  using 
conventional  pharmacotherapies  and  are  still  troubled  by  the  condition  have  the 
option of undergoing surgery to insert a penile prosthesis. A variety of implants are 
now available and are classified into malleable or inflatable implants.  These can be 
inserted electively.  However,  in a small proportion of patients  a prolonged priapic 
episode fails to respond to conventional treatment and in this scenario the option of an 
immediate penile prosthesis insertion is acceptable (90).
Embolisation: A Doppler study during the course of an acute episode of priapism in 
an  individual  who  is  initially  thought  to  be  suffering  from  idiopathic  stuttering 
priapism may reveal a high-flow priapism (142).  In this situation, intermittent high-
53flow episodes manifest as short lived episodes which leads to an initial diagnosis of 
stuttering priapism.  Therefore  if the history isn’t typical  of classical predominantly 
nocturnal  episodes  with  pain  then  a  Doppler  study  during  an  acute  episode  can 
delineate between the two. If the underlying diagnosis is of a high-flow priapism then 
arteriography followed by embolisation of an identified fistula would be the preferred 
management.
Subcapsular  orchidectomy:  With  the  development  and  improved  availability  of 
penile prosthesis, the use of subcapsular orchidectomy is now almost obsolete in this 
condition.
1.4  Pathophysiology of Low-Flow Priapism
Of  the  common  subtypes  described  previously,  low-flow  priapism  is  the  most 
prevalent form and one which is characterised by the development of ischaemia with 
potentially  devastating  consequences  for  erectile  function.  The  complete 
pathophysiology of low-flow priapism and the consequences of delayed treatment are 
still not fully understood. As it is a condition which can afflict male individuals of any 
age  and  potentially  result  in  the  development  of impotence,  by  understanding  the 
underlying alteration in the corpus cavemosum function we can develop an improved 
algorithm in the management of the disease in order to reduce the comorbidity.
1.4.1  Histological Changes in the Corpus Cavemosum following Priapism
Histologically the components of the corpus cavemosum undergo progressive 
changes as the duration of priapism increases. Electron microscopy has been used to 
retrospectively examine tissue samples from patients with low-flow priapism (143).Although  the  study  only  consisted  of 22  patients  it  found  that  interstitial  oedema 
occurs in the early stages of the disease process. In cases where priapism is of a short 
duration (less than  1 2  hours) the tissue consisted of minor endothelial defects with 
occasional lymphocytic infiltration with no alteration in the smooth muscle cells. It is 
only after  1 2 to  14 hours of low-flow priapism that trabecular smooth muscle cells 
show  the  beginning  of  focal  cytoplasmic  transformation  which  manifests  as  an 
increase in size of the perinuclear cytoplasm, endoplasmic reticulum, ribosomes and 
Golgi  apparatus.  At  between  24  to  48  hours  duration  widespread  endothelial 
destruction  and  exposure  of  the  basement  membrane  occurs  with  subsequent 
thrombocyte  adherence.  In  addition  to  this  the  smooth  muscle  cells  undergo  a 
transformation  as  described  above  as  well  as  necrosis.  Persistent  blood  stasis  for 
longer  than  two  days  is  associated  with  infiltration  of the  trabecular  tissue  with 
inflammatory  cells  and  smooth  muscle  cells  undergoing  necrosis  or  phenotypic 
change into fibroblast like cells.
From  this  description  the  first  cells  to  show  histological  alteration  are  the 
smooth muscle cells followed by the endothelial cells.
1.4.2  Dysregulatory  Mechanisms  in  Penile  Smooth  Muscle  Contraction  during 
Priapism:
As the duration of the penile erection becomes pathologically prolonged as in 
the case of low-flow priapism, the pC>2 progressively falls as the closed compartment 
prevents  replenishment  of  stagnant  blood  with  freshly  oxygenated  arterial  blood 
(144).  Broderick and Harkaway (91) analysed the change in the cavernous blood gas 
parameters  in  patients  presenting  with  prolonged  penile  erection  followingpharmacologically  induced  erections.  There  were  time-dependent  alterations  in the 
PO2, pH and pCC>2 during the erection. After 240 minutes the cavernous tissue is no 
longer perfused by highly oxygenated blood and the pH is reduced to less than 7.3, 
p02<6kPa and pCC>2 >8kPa.  After 360 minutes the parameters altered further and it 
was found that pH<7.27, pC>2<5.3kPa and pCC>2 >8.7kPa. By 720 minutes the pH had 
deteriorated  further to  6.89  and  pC>2<2kPa and  pCC>2>16kPa.  This  confirmed time- 
dependent changes in pH , pC>2 and pCC>2 in the corpus cavemosum during prolonged 
erections. The progressive changes in these parameters are illustrated in Figures 6 and 
7.  This  is the  only  study  which  has  directly measured  changes  in the  pH  and  pC>2 
levels in prolonged erections.  However, as yet there have been no studies which have 
investigated  the  alteration  in  the  glucose  concentration  of the  blood  in  the  corpus 
cavemosum.
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Figure  6:  Changes  in  the  corpus  cavemosum  pH  with  time  following  pharmacologically  induced 
erections. Modified from (91).
Linear (pH)
569  - r
8.5  - 
8
p02(kPa)  7-5
7  -
6.5  - 
6  -
5.5  -
100  200  300  400
Time (mins)
Figure 7: Changes in cavemosal p02 following pharmacologically induced penile erection.  Modified 
from (91).
The complex regulatory mechanisms involved in achieving a penile erection 
provide several  areas where dysregulation may occur and lead to a persistent penile 
erection.  During  the  flaccid  stage,  the  penile  smooth  muscle  is  in  a  state  of tonic 
contraction.  At this point the contractile factors have a greater effect on the smooth 
muscle compared to the relaxant factors. During a penile erection the parasympathetic 
responses  to  sexual  stimulation  result  in  the  relaxant  factors  outweighing  the 
contractile factors (66).  The balance is again reversed following ejaculation.  During 
priapism this imbalance  appears to be maintained in favour of persistent cavemosal 
smooth muscle relaxation or lack of contraction.
Currently  there  is  no  clear  consensus  available  in  the  medical  literature 
relating to the initiating events which leads to a prolonged penile erection. Work has
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57focussed  on  the  factors  which  maintain  tumescence,  in  particular  the  metabolic 
changes in the corpus cavemosum (8 8 ; 144-146). The initiating mechanisms are likely 
to  be  multifactorial  involving  central  neuronal  pathways,  alterations  in  the  corpus 
cavemosum  microenvironment,  modulation  of  the  smooth  muscle  contractile 
machinery and aberrant neurotransmitter regulation in the corpus cavemosum (147). 
Limited  scientific  work  has  been  performed  investigating  the  role  of the  central 
neuronal  pathways  in  the  initiation  of  priapism.  A  disturbance  in  the  central 
neurotransmission mediating penile erection (148) or abnormal activation in the reflex 
mechanisms involved in penile erection on genital stimulation have been hypothesised 
as being involved in the initiation of mechanisms leading to priapism (106). Loss of 
the medullary reticular formation neurons which normally inhibit male spinal sexual 
reflexes  has  been  proposed  using  a  mouse  model  (149).  The  sympathetic  nervous 
system is the major effector system in maintaining detumescence through the release 
of noradrenaline.  Failure of the sympathetic system may also predispose individuals 
to the development of priapism (87; 150).
The  main  neurotransmitter  which  is  involved  in  penile  smooth  muscle 
relaxation is NO. Whether unregulated amounts of NO initiate the response has been 
investigated by Kim et al (81). This group found that there is no central role of NO in 
the maintenance  of the  erection during priapism.  As  explained previously,  the  low 
p0 2  levels which occur during a prolonged penile erection would be unable to act as a 
substrate  for  NOS  to  maintain  the  production  of NO.  Alternatively  the  failure  of 
endogenous  contractile  factors  such as  noradrenaline  or endothelin-1  to  adequately 
induce  smooth  muscle  contraction  will  contribute  to  the  maintenance  of corporal 
smooth muscle relaxation. However, clinically the instillation of a-adrenergic agonists 
is  successful  in reversing the  condition  in  a proportion  of patients  but there  is  no
58indication  in  the  literature  as  to  the  success  rate  of this  non  surgical  mode  of 
treatment.  What  is  more  likely  is  that the  smooth muscle  dysfunction  occurs  as  a 
result  of  the  failure  of  smooth  muscle  contractile  machinery  secondary  to  the 
alterations in the corporal microenvironment.
The effects of hypoxia on corporal  smooth muscle was  initially investigated 
by Broderick et al (144). Strips of rabbit corpus cavemosum were subjected to anoxia 
by gassing with a mixture of 95% N2 and 5% CO2 and the contractile responses were 
recorded.  The  corporal  smooth  muscle  tone,  contractile  activity  to  a  agonists  and 
electrical field stimulation were all reduced under anoxic conditions. Further studies 
(8 8)  concluded  that  the  reduction  in  smooth  muscle  tone  is  due  to  increased 
intracellular  calcium  levels.  However,  during  prolonged  ischaemic  priapism,  the 
tissue  is  subjected  not  only  to  hypoxia,  but  the  microenvironment  becomes 
increasingly acidotic (144) . The effects of acidosis per se was investigated by Saenz 
De Tejada et al (145) and showed that the smooth muscle contractility is impaired by 
acidosis. In vivo studies were performed by Moon et al (151) who used anaesthetised 
cats  and  hyperventilation  to  induce  metabolic  acidosis.  In  this  study  the 
intracavemous  pressure  measurements  indicated  that  the  smooth  muscle  failed  to 
contract and the overall intracavemous pressure was reduced.
1.4.3  Ischaemia/Reperfusion Injury
Low-flow  priapism  is  analogous  to  a  closed  ischaemic  compartment  for 
cavemosal smooth muscle. Aspiration or instillation of a-adrenergic agonists can be 
successful  in  reversing  this  state.  Whether the  perfusion  of cavemosal  tissue  with 
oxygenated blood results in a reperfusion type injury is not completely understood. 
Although ischaemia/reperfusion injury has been extensively studied in vascular and
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of studies. Evliyaoglu and co-workers (152) examined the effects of allopurinol as a 
reactive  oxygen  species  scavenger in a reperfusion injury model  of veno-occlusive 
priapism using  constriction rings  on rat penis.  Those  animals  receiving  allopurinol 
showed reduced lipid peroxidation which is used as a marker of reperfusion injury. A 
study using anaesthetized rabbits exposed to low oxygen tension found a significant 
increase  in  lipid  peroxidation  and  myeloperoxidase  activity  following 
ischaemia/reperfusion (146).
1.5  Design and Aim of This Study
Up until now the investigation of low-flow priapism has involved the use of 
both in vitro and in vivo models which have attempted to reproduce the  change in the 
corporal microenvironment parameters namely hypoxia and acidosis. Apart from the 
work of Broderick and Harkaway (91) which documented the temporal change in the 
corporal microenvironment with regards to the degree of acidosis and hypoxia, there 
have been no documented studies which have analysed corporal blood aspirated from 
those  patients  who  have  presented  with  low-flow  priapism  which  is  refractory  to 
conventional non surgical management. Therefore the initial part of our study was to 
document  the  degree  of hypoxia,  acidosis  and  also  the  glucose  level  found  in the 
corporal blood of patients with refractory priapism in order to identify whether there 
is  a  critical  level  in  these  parameters  which  induces  a  failure  in  the  contractile 
machinery.
Previous  studies  which  have  utilised  an  in  vitro  model  to  investigate  the 
effects  of hypoxia and  acidosis  on  corporal  smooth muscle  did  not  investigate the
60recovery of corporal smooth muscle tone following exposure to these conditions. It is 
not  known  whether  prolonged  exposure  to  hypoxia  or  acidosis  either  alone  or  in 
combination can cause irreversible corporal smooth muscle dysfunction. Hypoxia and 
acidosis coexist in low-flow priapism states and may perpetuate the failure of smooth 
muscle relaxation  in response to  a  agonist treatment.  However,  if these  conditions 
were  to  be  reversed,  which  clinically  is  achieved  by  aspiration  of blood  from  the 
corpus cavemosum,  then would the  smooth muscle tone recover completely  or are 
these  two  parameters  the  predominant  mediators  of irreversible  cavemosal  smooth 
muscle dysfunction.
Currently  in  the  clinical  setting  the  aspiration  of  blood  from  the  corpus 
cavemosum  is  a  fundamental  step  in the  initial  management of patients presenting 
with  priapism.  Aspirates  are  analysed  in  a  blood  gas  analyser  and  the  degree  of 
hypoxia and acidosis is used as a gauge in order to classify the priapism into a high- 
flow  or  a  low-flow  subtype.  However,  despite  varying  degrees  of  hypoxia  and 
acidosis, some of these individuals manage to achieve detumescence using aspiration 
alone whereas others also require the instillation of a-adrenergic agents.
Our  institution  is  a  major  national  referral  centre  for  acute  priapisms. 
Therefore by analysing the results of corporal blood aspirates from those patients who 
fail to respond to conventional treatment we can investigate the underlying parameters 
which lead to this  clinical  scenario by developing a reproducible  in vitro model  of 
low-flow priapism.
In  order  to  identify  the  parameters  mediating  irreversible  smooth  muscle 
dysfunction,  I  have  developed  a model  of ischaemic  priapism  using  rabbit  corpus 
cavemosum. Each parameter was investigated individually in order to assess whether
61for instance hypoxia alone or in combination with acidosis can result in irreversible 
smooth muscle dysfunction.
The  limitations of this  study are that the availability of human tissue for in 
vitro work is limited.  In vitro work using human tissue mainly utilised tissue from 
patients  undergoing  gender reassignment  surgery  and those  undergoing  penectomy 
operations for penile cancer.
Due  to  the  limited  availability  of  human  corpus  cavemosum  tissue,  the 
majority of the  in vitro work was carried out using rabbit corpus cavemosum.  This 
tissue has been used  extensively  in basic  science research into  erectile  dysfunction 
and is reproducible.
Aims of the study:
1.  To identify the cavemosal blood parameters in patients presenting with low- 
flow priapism which fail to achieve penile detumescence.
2.  To assess smooth muscle dysfunction in these patients dynamically.
3.  To develop an in vitro model of ischaemic priapism
4.  To investigate potential pharmacological agents which may reduce the degree 
of smooth muscle dysfunction and promote detumescence.
5.  To  investigate  the  underlying  factors  responsible  for  irreversible  smooth 
muscle dysfunction.
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MATERIALS AND METHODS
2.1 Analysis of Cavemosal Blood Aspirates from Patients Presenting with 
Priapism
Patients  (n=10)  presenting  to  our  department  with  clinically  diagnosed 
priapism underwent a penile Doppler study. All adult patients with a first presentation 
of priapism were included. Patients with a history of sickle cell disease and stuttering 
priapism or those with idiopathic stuttering priapism were excluded from the study. 
Penile Doppler studies were performed by a radiologist using a 10MHz probe. Those 
patients diagnosed with a low-flow priapism on Doppler studies underwent aspiration 
of blood  from  the  corpus  cavemosum  as  part  of the  initial  management  of the 
condition.  Samples  were  transported  on  ice  in  a  syringe  to  be  analysed  in  an 
automated blood gas analysis chamber in order to measure the pH, pC>2 and glucose.
2.2 In vitro Experiments Using Human Corpus Cavemosum
Experiments on human corpus cavemosum tissue were approved by the Joint 
UCL/UCLH  Ethics  Committees  REC  Ref  03/0158.  Normal  human  corpus 
cavemosum was obtained from patients undergoing partial penectomy or total penile 
amputation for penile carcinoma.  At the time of the operation a 2cm long piece of 
corpus  cavemosum  was  dissected  from  the  surgical  specimen  and  the  tissue  was 
immediately placed into ice cold Krebs solution.
Priapic patients that were confirmed as having low-flow priapism on the basis 
of a clinical history, corporal aspirates indicating ischaemia (pH<7.25 and p02<6kPa) 
and penile Doppler studies and who were unable to achieve detumescence following
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undergo an open biopsy of the corpus cavemosum under general  anaesthesia. They
were counselled regarding the purpose of the biopsy and given the option of having a 
malleable penile prosthesis inserted if the biopsy showed that the penile tissue was 
non viable. At the same time, a 1cm biopsy of the corpus cavemosum was removed 
and immediately placed into Krebs solution.
The tissues were dissected into smaller 0.3cm x 0.5cm pieces and mounted in 
superfusion  chambers  under  0.6g tension.  After  a  30  minutes  equilibration period, 
increasing  concentrations  of  phenylephrine  (O.lpM-lmM)  were  added  to  the 
perfusion fluid and the isometric tension was recorded simultaneously. At the end of 
the experiment, scopolamine (lOpM) and guanethidine (lOpM) were added to block 
cholinergic and noradrenergic pathways followed by electrical field stimulation (EFS; 
50V, 0.3ms pulse duration, 1-50 Hz, for 5 s, every 2 minutes).
2.3  In vitro Experiments Using Rabbit Corpus Cavemosum.
Male New Zealand white rabbits were supplied by Harlan, UK and housed in 
the Biological Services Unit, Wolfson Institute for Biomedical Research between 16- 
19°C conforming to Home Office regulations. The animals were allowed to settle in 
for a week before being used. The rabbits were killed using an intravenous overdose 
of pentobarbitone  into  the  marginal  vein  of  the  ear  (Figure  8).  The  penis  was 
identified  (Figure  9)  and  dissected  up  to  the  level  of the  crural  attachment  to  the 
ischium.  Sharp dissection was used to free the penis from the pubic bones and the 
organ  was  immediately  placed  into  Krebs  solution  (Table  2)  pre-oxygenated  with 
carbogen  (95%  O2  and  5%  CO2)  at  room  temperature.  Dissection  of the  residual 
adventitial tissue  (Figure  10)  was  followed by  a longitudinal  incision of the tunica
64albuginea  which  encircles  the  corpus  cavemosum.  The  cavemosal  tissue  was 
dissected free of the tunica albuginea and four strips measuring 0.5cm x 0.3cm were 
obtained.
Marginal vein
Figure 8: Marginal vein of the ear demonstrated following shaving of the ear fur.
Testicle
Penis
Figure 9: Surrounding tissue dissected to expose the penis.
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Crural attachment
Figure 10: Body of the penis following removal of the urethra
Cavemosal strips were mounted horizontally in superfusion chambers between 
the  two  ring  electrodes  of 4  mm  in  diameter.  Each  double jacketed  chamber  was 
maintained at 37°C.  The chambers were perfused with modified Krebs solution at a 
constant  flow  rate  of  1ml  per  minute  using  a  Miniplus  2  (Gilson,  Luton,  United 
Kingdom) peristaltic pump. One end of the preparation was tied to an FT03C (Grass 
Instruments,  Quincy,  Massachusetts, USA) force displacement transducer connected 
to a Linearcorder WR 3101  (Graphtec, Tokyo, Japan) and a computer for recording 
isometric  tension  (Figure  11).  A  schematic  diagram  of the  superfusion  system  is 
shown in Figure 12.
The  preparations  were  stretched  with  a  tension  of  0.6g.  They  were  then 
allowed to equilibrate for 60 minutes. The test conditions were induced according to 
the protocol explained below and the experiments were terminated by adding prazosin 
to the test solution in order to identify the experimental baseline.
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Figure  11:  Tissue  strip  placed  in  the  superfusion  chamber  with  one  end  fixed  and  the  other  end 
attached to a transducer.
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Figure 12  Schematic illustration of the experimental set up
2.3.1  Gas Preparations
Under normal conditions the Krebs solution was gassed with carbogen (95% 
O2 and 5% CO2). In order to induce hypoxia, the gas was changed to 95% N2 and 5%C02. Measurement of the p0 2 in the reservoir and chamber showed that the p0 2 was 
over  100mmHg(13.3kPa)  when  gassed  with  carbogen.  When  the  gas  mixture  was 
changed to 95% N2 and 5% C02, the p0 2 in the reservoir was 5-7mmHg(0.7-0.9kPa) 
and due to equilibration with the silicone tubing it was 40-50mmHg(5.3-6.7kPa)  in 
the chamber.
2.3.2 Acidotic Krebs Solution
The HCO3' composition of the Krebs solution was reduced from  16.3mM to 
5mM in order to reduce the pH to 6.9. The osmolarity was maintained by equimolar 
addition of NaCl such that the final concentration of NaCl was 144mM. The pH of the 
medium  was  periodically  monitored  using  a pH  meter (AR15  pH  meter,  Accumet 
Research, Fisher Scientific, UK).
2.3.3 Glucopenia
Experiments requiring glucopenia used modified Krebs solution in which the 
glucose was omitted.
The  contents  of  the  Krebs  solution  in  normal,  acidotic  and  glucopenic 
conditions are summarised in Table 2.
68Normal Hypoxic Acidotic Glucopenic
NaCl 133mM 133mM 144mM 133mM
KCl 4.7mM 4.7mM 4.7mM 4.7mM
NaH2P04 16.3mM 16.3mM 16.3mM 16.3mM
MgS04 0.6 ImM 0.61mM 0.61mM 0.6 ImM
NaHCOj 16.3mM 16.3mM 5mM 16.3mM
CaCl2 2mM 2mM 2mM 2mM
Glucose 7.8mM 7.8mM 7.8mM OmM
Dexamethasone 0.0 ImM 0.0 ImM 0.0 ImM 0.0 ImM
pH 7.4 7.4 6.9 7.4
p 0 2 >100mmHg 40-50 mmHg >100mmHg >100mmHg
Table 2: Composition of the modified Krebs solution for each experimental protocol
2.4  Experimental Protocols Using Rabbit Corpus Cavemosum
2.4.1  Calculating the ECso for Phenylephrine in Normal Conditions
Once  the  tissue  preparations  were  set  up  in  the  superfusion  chambers  as 
explained above, the tissue was allowed to equilibrate for one hour at 37°C. After the 
equilibration period, cumulative concentrations of phenylephrine (0.1-300 pM) were 
added  to  the  reservoir.  Isometric  tension  was  recorded  simultaneously  until  the 
maximum tension was achieved. The ECgo value for phenylephrine was calculated by 
plotting  the  tension  as  a  percentage  of the  maximum  tension  and  calculating  the
69concentration  required  to  achieve  80%  of the  maximum  tension  as  illustrated  in 
Figure  14. This calculated concentration was then used to pre-contract the tissues in 
the subsequent experiments.
2.4.2 Eliciting Nitrergic Relaxations
Following a one hour equilibration period,  electrical  field stimulation (EFS; 
50V,  0.3ms  pulse  duration,  0.5-50  Hz,  for  5s,  every  2  min)  was  initiated. 
Scopolamine (10 pM) and guanethidine (10 pM) were then added to block cholinergic 
and  noradrenergic  components  respectively.  The  cavemosal  strips  were  then  pre­
contracted with 20pM phenylephrine. Under these conditions the strips maintained a 
tone and EFS elicited reproducible relaxation responses.
2.4.3 Acute Effect of Hypoxia, Acidosis and Glucopenia on the Elevated Tone
Tissue  strips  were  pre-contracted  with  ECgo of phenylephrine  following the 
equilibration period. The isometric tension was recorded simultaneously as conditions 
of hypoxia, acidosis or glucopenia or their various combinations were instilled.
2.4.4  Time  Course  for  the  Recovery  of  Phenylephrine-Induced  Tone  after 
Reversal of Combination of Hypoxia, Acidosis and Glucopenia
Tissue  strips  were pre-contracted with  ECgo  of phenylephrine  following the 
equilibration  period.  The  tension  was  recorded  simultaneously  as  the  tissue  strips 
were superfused  in a combination of hypoxia, acidosis and glucopenia.  At various 
time points between 30 minutes to 6 hours the conditions were reversed using normal 
Krebs  solution  containing phenylephrine  and  gassed  with  carbogen.  The  recovered 
tone was expressed as the percentage of the initial tone. The tone from a control tissue
70which was superfused with normal Krebs solution was also recorded for up to 6 hours 
to assess the spontaneous loss of tone.
2.4.5  Recovery  of  Phenylephrine-Induced  Tone  after  Reversal  of  Hypoxia, 
Acidosis and Glucopenia
Tissue  strips  were  pre-contracted  with  ECso of phenylephrine  following the 
equilibration period. The isometric tension was recorded simultaneously as conditions 
of hypoxia, acidosis or glucopenia or their various combinations were instilled. The 
strips were exposed to these conditions for 4 hours.  The tone from a control tissue 
which was  superfused  with normal  Krebs  solution was  also  recorded to  assess the 
spontaneous loss of tone during this time period. At the end of 4 hours, the conditions 
were reversed using normal Krebs solution containing phenylephrine and gassed with 
carbogen. The recovered tone was expressed as the percentage of the initial tone.
2.4.6  Cumulative  Concentration  Response  to  Phenylephrine,  Endothelin-1  and 
U46619 with and without Hypoxia, Acidosis and Glucopenia
Tissue strips were divided randomly into two groups.  Each group underwent 
repeat  experiments  after  precontraction  with  endothelin-1  (33.33nM)  or  U46619 
(50nM) as opposed to phenylephrine. The first group was superfused in normal Krebs 
solution  for  4  hours.  The  second  group  was  superfused  with  a  combination  of 
hypoxia, acidosis and glucopenia for 4 hours. At the end of 4 hours, both groups were 
superfused  with  normal  Krebs  solution  for  30  minutes.  Then  increasing 
concentrations of phenylephrine (0.1  - 300 pM), endothelin-1  (33.33nM) or U46619 
(50nM) were added.
712.4.7 Effect of Hypoxia, Acidosis and Glucopenia on Nitrergic Responses
Tissue strips were pre-contracted with ECgo of phenylephrine and were then 
subjected to 4 hours of a combination of hypoxia, acidosis and glucopenia.  During 
this  period  nitrergic  relaxation  responses  were  measured  and  their  magnitude  was 
expressed as a percentage  of the tone.  The nature of the relaxation responses were 
confirmed  by  addition  of an  inhibitor of NO  synthase  (N“-nitro-Z-arginine  methyl 
ester; L-NAME, 500 pM) or the nerve blocker tetrodotoxin (TTX, 3 pM).
2.4.8 Investigation of Putative Therapeutic Agents
Tissue strips were pre-contracted with ECgo of phenylephrine and were then 
subjected  to  4  hours  of a  combination  of hypoxia,  acidosis  and  glucopenia.  The 
effects of cumulative concentrations of some agents, which have been suggested to be 
protective against tissue  damage to  ischemia or have the  ability to  reverse  smooth 
muscle  relaxation,  were  then  tested  on  the  tone  of the  strips.  These  agents  were 
calcium  (l-10pM),  the  direct  calcium  channel  activator  Bay  K  8644  (lpM),  N- 
acetylcysteine  (anti-oxidant,  lOOpM), Nw -nitro-L-arginine  methyl  esther  (L-NAME, 
NO  synthase  inhibitor,  500pM),  digoxin  (Na/K  ATPase  inhibitor,  lOpM  )  and 
glutathione (500pM).
2.4.9 Experiments Utilising Metabolic Inhibition
In  order  to  reproduce  the  conditions  of  glucose  depletion  and  hypoxia, 
iodoacetic acid (500pM) and myxothiazol (500pM) were used to inhibit the glycolytic 
pathway  (interaction  with  glycerol  phosphate  dehydrogenase)  and  the  electron 
transport chain (inhibition of mitochondrial complex III) respectively. The iodoacetic 
acid  was  added  following  the  equilibration  period  and  pre-contraction  with
72phenylephrine  (ECgo).  Similarly  in  separate  experiments myxothiazol  was  added  at 
the end of the equilibration period and pre-contraction with phenylephrine (ECgo) and 
tone was recorded simultaneously.
2.5  Measurement of ATP Concentrations
Experiments  were  repeated  where  tissue  strips  underwent  immediate  snap 
freezing in liquid nitrogen at the following four time points: at the end of 60 minutes 
equilibration, after pre-contraction with phenylephrine (20 pM), following 4 hours of 
combination  of  hypoxia,  acidosis  and  glucopenia  and  following  one  hour  of 
reperfusion with normal Krebs solution. Four strips from the same animal were used 
for each time point and the experiment was repeated four times.  The frozen tissues 
were crushed into a fine powder using a stainless steel pestle and mortar on dry ice. 
200 pi of 70% perchloric acid was added to the powder and vortex mixed vigorously. 
The preparation was then centrifuged for  10 minutes (13,000 g, 4°C).  150 pi of the 
supernatant was neutralised with 20pl of 5M K2CO3.  After a further  10 minutes of 
centrifuging (13,000 g, 4°C) ATP was measured in duplicate in the supernatant using 
an ATP bioluminescent assay kit (Sigma, Poole, UK) according to the manufacturer’s 
instructions.  ATP  standards  (InM-lOpM;  Sigma,  UK)  were  used  to  construct  a 
standard curve. As ATP is consumed, light is emitted when firefly luciferase catalyses 
the oxidation of D-luciferin.
A   J  1   1   -X-  •  .  TW
A i r   T L A icnenn ►   Adenyl-lucilenn  1   111
Adenyl-lucifenn +02 * Oxyluciferin + AMP +CO2 + Light
73Protein concentration in each sample was measured using Bio-Rad protein 
assay reagent (Bio-Rad, Hemel Hempstead, UK) based on the dye-binding procedure 
of Bradford  (153).  The  ATP  concentration  of each  sample  was  expressed  as pmol 
ATP/pg protein.
2.6  Histochemistry  and  Immunofluorescence  of  Tissue  Exposed  to  Hypoxia, 
Acidosis and Glucopenia in Combination
Tissue strips were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer at 
four different time points: at the end of 60 minutes equilibration, after pre-contraction 
with  phenylephrine,  following  4  hours  of  combination  of  hypoxia,  acidosis  and 
glucopenia and  following one hour of reperfusion with normal  Krebs  solution.  The 
specimens  were  processed  for  immunofluorescence  and  for  routine  haematoxylin 
eosin (H&E) staining performed by Dr A. Dogan at the Histopathology Department, 
University  College  London.  For  immunofluorescence;  after  fixation  in  4% 
paraformaldehyde, the tissues were transferred into 30% sucrose in phosphate buffer 
and kept at 4°C overnight. The samples were then frozen in OCT compound (BDH, 
Poole, UK) and serial cryosections at 20pm interval were obtained using a cryostat 
(18°C;  2800  Frigocut-E;  Leica,  Bensheim,  Germany).  The  sections  were  dried  on 
gelatine-coated  slides  for  2  hours  at  room  temperature  and  then  incubated  with 
phosphate  buffered  saline  (PBS)  containing 0.1%  TritonX-100  and  5%  goat  serum 
(Vector, Burlingame,  California).  The slides were incubated with TUNEL (terminal 
deoxynucleotidyl  transferase-mediated  dUTP  nick-end  labelling)  reaction  mixture 
(Roche, Lewes, UK) overnight at 37°C and then with a monoclonal antibody against 
smooth muscle specific a-actin (1/250; Sigma, UK) for 2 hours at room temperature 
followed by fluorescein-conjugated anti-mouse IgG (1/100; raised in goat; Chemicon,
74Harrow, UK) for 1 hour at room temperature. The images were obtained using a laser- 
scanning  confocal  microscope  (Leica  TCS-DMRE,  Germany).  Image  analysis  was 
performed  using  Leica  Confocal  Software  (Version  2.00,  build0871,  Germany).  In 
order to avoid day-to-day variation in signal intensity, several sections from different 
experimental groups were immunostained and analysed in the same batch on the same 
day. The laser intensity and gain functions were set according to the control tissue; 
thereafter,  these  settings  were  applied to  all  sections  from  all  experimental  groups 
within  the  same  batch.  The  results  from  TUNEL  staining  were  expressed  as  the 
percentage of smooth muscle cells with TUNEL-positive nuclei.
752.7 Chemicals and Drugs
Drugs utilised and suppliers
Phenylephrine hydrochloride Sigma
Scopolamine hydrochloride Sigma
Guanethidine monosulphate Sigma
Bay K 8644 Calbiochem
Glutathione Sigma
N-acetylcysteine Sigma
Digoxin Sigma
Prazosin Sigma
U46619 Calbiochem
N“-Nitro-L-arginine methyl ester 
hydrochloride
Sigma
Dexamethasone Sigma
Myxothiazol Sigma
Ammonium formate BDH
Ammonium phosphate Sigma
Potassium carbonate Sigma
Endothelin-1 Sigma
ATP,ADP,AMP,p methylene ATP Sigma
Table 3: Chemicals utilised for the experimental procedures and suppliers.
762.8  Statistical Analysis and Presentation of the Results
All results were expressed as mean ± standard error of mean. Isometric tension 
was expressed as a percentage of the initial tone. Statistical analysis for pharmacology 
experiments was performed using Student’s t-test for unpaired observations. For the 
ATP measurements Wilcoxon signed rank test for paired samples was used where the 
tissues  from  the  same  animal  were  paired.  P  values  less  than  0.5  was  considered 
significant.  The  statistical  analysis  was  performed  using  GraphPad  Prism  software 
(version 3.00, GraphPad Software Inc, San Diego, California, USA).
77CHAPTER 3
RESULTS
3.1  Analysis of Blood Aspirates from Patients Presenting with Priapism
Patients presenting with a history suggestive of low-flow priapism which was 
unresponsive to pharmacological  intervention underwent penile  Doppler studies and 
corporal  blood  aspirations.  Of the  10  patients  presenting  to  our  department  with 
priapism,  a  total  of  7  patients  underwent  full  investigation  with  corporal  blood 
aspirations  together  with  the  penile  Doppler  studies  performed  by  one  of  two 
radiologists (Table 4). The corporal blood aspirations demonstrated that the blood in
the corpus cavemosum is acidotic, hypoxic and also glucopenic.
Patient Duration of 
priapism
pH p02 (kPa) Glucose
(mmol/l)
Penile Doppler
1 60 Hours 6.9 1.6 0 Not done
2 4 days 7.1 2.3 0.2 Low-flow
3 7 days 7.0 2.1 0.3 Low-flow
4 8 days 6.9 1.7 0 Low-flow
5 9 days 7.05 1.82 0 Low-flow
6 10 days 6.9 1.5 0.1 Low-flow
7 72 Hours 7.19 4.4 2.7 High-flow
Table 4  Results of the corporal blood analysis from patients presenting with prolonged low-flow 
priapism. Comparison is made with the outcomes from the penile Doppler studies.
783.2  In Vitro Experiments Using Human Corpus Cavernosum
Normal  human  corpus  cavernosum  using  tissue  obtained  from  patients 
undergoing penectomy operations showed a concentration response to phenylephrine 
as illustrated in Fig 13. The calculated ECgo was 3pM.
Patients  who  failed  conventional  management  for  low-flow  priapism 
underwent an immediate insertion of a penile prostheses. Human corpus cavernosum 
was obtained  from  these  patients  and the tissue was mounted  as  described  (section 
2.2) and cumulative concentrations of phenylephrine (0.1-300 pM) were added to the 
reservoir.  In  all  6  cases  of  suspected  low-flow  priapism  there  was  a  failure  of 
contraction  of  the  tissue  strips  despite  using  high  doses  of phenylephrine  up  to 
300pM. Again this is illustrated in  Fig 13.
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Figure 13. Concentration response curve to phenylephrine in normal human corpus 
cavernosum  tissue  (n=4).  This  is  compared  to  the  response  of isolated  human 
corpus cavernosum from patients presenting with low-flow priapism (n=6).
793.3  In vitro Experiments Using Rabbit Corpus Cavernosum
3.3.1  Calculating the ECgo for Phenylephrine in Normal Conditions
In order to establish the ECgo value, cumulative concentrations (0 .1 -  300pM) 
of phenylephrine were added to the reservoir. Figure  14 illustrates the concentration 
response of rabbit corpus cavernosum to phenylephrine. From this curve an ECso of 
20 pM was calculated.
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Figure 14. Phenylephrine concentration-response curve using rabbit corpus 
cavernosum. Each data point represents the mean ± s.e. of mean. Experiments 
utilized a total of 11 tissue strips from 4 different animals.
3.3.2  Eliciting Nitrergic Relaxations Using Rabbit Corpus Cavernosum
After inhibition of cholinergic and noradrenergic pathways with scopolamine 
(10 pM) and guanethidine (10 pM) respectively, the tone of the strips was elevated 
with 20  pM phenylephrine.  Once the tone was stabilised, application of EFS  (50V, 
0.3 ms pulse duration, for 5 s, every 2 min, 0.5-50 Hz) elicited reproducible relaxation
80responses  (Figure  15).  These  relaxations  were  frequency-dependent  and  were 
inhibited  by N“-nitro-L-arginine  methyl  ester  (L-NAME,  500  pM)  or tetrodotoxin 
(TTX, 3 pM).
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Figure 15. Representative tracing illustrating  EFS (50V, 0.3ms pulse, frequency 
0.5-50 Hz) induced nitrergic relaxation of tissue strips under control conditions.
Each •  indicates the point of stimulation.
3.3.3  Acute Effect of Hypoxia, Acidosis and Glucopenia on the Elevated Tone
The constituents of the Krebs solution were altered such that each parameter 
was  investigated  either  individually  or  in  combination.  Hypoxia,  acidosis  or 
glucopenia alone reduced the tone of pre-contracted strips to 28.4±2.9%, 59.6±7.5% 
and 9.4±3.8% of the initial tone respectively.  Combinations of glucopenia+acidosis, 
glucopenia+hypoxia and hypoxia+acidosis reduced the tone to  13.9±2.8%, 8.1±2.5% 
and 6.4±3.1% of the initial tone respectively.  The combination of hypoxia, acidosis 
and  glucopenia  resulted  in  a  loss  of tone  which was  8 .2± 1.6%  of the  initial  tone. 
These results are summarised in Figure 16. The time taken to reach the minimum tone 
is shown later in Table 5 for each condition. Glucopenia resulted in the slowest rate ofloss of tone.  Acidosis  alone resulted in the most rapid reduction in tone to plateau 
levels.  With  regards  to  recovery  following  the  reversal  of each  condition,  again 
acidosis alone resulted in the fastest rate of recovery.
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Figure  16:  Acute  effect  of hypoxia  (H),  acidosis  (A),  glucopenia  (G)  and  their  combinations  to 
phenylephrine-induced tone of the.rabbit corpus cavernosum.  Control (C) tissue was superfused with 
normal  Krebs  solution.  The  tone  was  measured  when  the  tissue  reached  a plateau.  Each  data point 
represents  mean  ±  s.e.  of  mean  of  4-10  separate  tissue  strips  from  different  animals.  *P<0.05 
significantly different from control; +P<0.05 significantly different from other treatments.
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823.3.4  Effect of Prolonged Exposure to Hypoxia, Acidosis and Glucopenia on the 
Elevated Tone
In my initial experiments prolonged exposure to hypoxia or acidosis produced 
significant loss of tone which was partially reversible even at 48 hours (not shown). 
However  the  tone  of the  control  tissue  also  showed  a  progressive  decline  which 
became  significant after  6  hours.  Figure  17  shows the progressive reduction in the 
tone over  1 2 hours when tissue strips were exposed to hypoxia alone or hypoxia and 
acidosis in combination.
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Figure  17:  Reduction  in  corpus  cavernosum  tone  following  prolonged  exposure  to  hypoxia  and 
acidosis  either alone  or  in  combination.  Note  that the  control tissue  lost  significant  amount  of tone 
especially after 6  hours.  Each  data point represents mean ±  s.e.  mean.  For each  condition 4-8  tissue 
strips were used from different animals.
833.3.5  Time  Course  for  the  Recovery  of  Phenylephrine-Induced  Tone  after 
Reversal of Combination of Hypoxia, Acidosis and Glucopenia
The control tissue  lost part of its initial tone during the  first  6 hours of the 
experiment. The combination of hypoxia, acidosis and glucopenia resulted in a loss of 
tone  which  progressively  became  irreversible  after  reversal  of the  conditions.  A 
sudden drop in the recovered tone was observed between  1   and 2 hours (Figure  18). 
Since the maximum irreversibility was reached at 4 hours, this time point was used in 
the subsequent experiments whereby the conditions were reversed.
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Figure 18: Time course for the recovery of phenylephrine-induced tone after reversal of combination 
of hypoxia,  acidosis  and  glucopenia  (H+A+G;  open  squares).  The  control  tissue  (Control;  solid 
squares) lost some of its tone during 6 hours. The loss of tone became progressively irreversible after 
exposure to H+A+G reaching a maximum at 4 hours. The tone was measured when the tissue reached a 
plateau after reversal of the conditions. Each data point represents mean ± s.e. of mean of 4-10 separate 
tissue  strips  from  different  animals.  *P<0.05;  **P<0.0001  significantly  different  from  control  at the 
same time point.
843.3.6  Recovery  of  Phenylephrine-Induced  Tone  after  Reversal  of  Hypoxia, 
Acidosis and Glucopenia
In  order  to  ascertain  which  parameter  caused  irreversible  tone  loss,  the 
experiments  were  repeated  using  each  individual  parameter  either  alone  or  in 
combination during a 4 hour superfusion period.
At  the  end  of 4  hours,  by  reintroducing  each  parameter,  the  recovery  of 
smooth muscle tone was recorded. Expressed as a percentage of the initial tone, the 
results showed almost complete recovery following the reversal of all the parameters 
except  when  glucopenia  was  combined  with  hypoxia  or  in  the  presence  of  a 
combination  of hypoxia,  glucopenia  and  acidosis  (Figures  20).  The  time  taken  to 
recover  and  to  reach  a plateau  is  summarised  in  Table  5  for  each  condition.  The 
fastest recovery was observed when acidosis was used alone.
85Table 5: Time in minutes to reach the minimum recorded tone upon exposure to different conditions 
(Tl) and to recover (to reach a plateau) after 4 hours of exposure (T2).  The measurement of T1 and T2 
are  explained  below  in  a  sample  tracing.  The  results  are  expressed  as  mean  ±  s.e.m.  *P<0.05 
significantly different from hypoxia Tl  or acidosis Tl.  **P<0.05 significantly different from hypoxia 
T2 or glucopenia T2.
Condition Tl T2 n
Hypoxia 29.1 ±2.2 20.8 ± 1.5 6
Acidosis 13.7 ±  1.1 11.5 ± 1.0** 4
Glucopenia 74.1 ± 15.0* 31.1 ±4.1 5
Glucopenia + Acidosis 70.4 ±7.1 22.9 ± 1.1 5
Glucopenia + Hypoxia 45.6 ±4.4 32.7 ±3.3 5
Hypoxia + Acidosis 52.7 ± 4.6 42.1 ±4.8 5
Hypoxia + Acidosis + 
Glucopenia
39.1 ±1.9 24.1 ±2.5 1 0
Tl -  Time to reach minimum recorded tone 
T2 -  Time to recovery
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Figure 19. Representative trace showing the effects of hypoxia alone on the tone of precontracted 
tissue strips and the recovery following the reversal of hypoxia.
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Figure 20:  The  recovery  of phenylephrine-induced tone  after reversal  of hypoxia (H),  acidosis  (A), 
glucopenia (G) or their combinations after 4 hours. The control tissue (C) lost some of its tone during 
this time period.  The  loss  of tone  was  irreversible only  in  G+H  and H+A+G  groups.  The tone  was 
measured when the tissue reached a plateau after reversal of the conditions. Each data point represents 
mean  ±  s.e.  of mean  of 4-10  separate  tissue  strips  from  different  animals.  *P<0.05  significantly 
different from control.
Representative traces from each experimental condition showing the effects of the 
tone of tissue strips and the recovery once the conditions are reversed are illustrated in 
Figure 19 for hypoxia and Figures 21 to 27. For the sake of clarity, EFS induced 
relaxations are shown although the point of application of EFS has been omitted.
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Figure 21. Representative trace showing control tissue strips 
subjected to superfusion for 4 hours. There was no significant 
change in the tone throughout this period.
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Figure 22. Representative tracing illustrating the effects of acidosis alone on 
precontracted tissue strips. EFS induced nitrergic relaxations are abolished by the 
addition of L-NAME (illustrated by +) and the precontraction with phenylephrine 
is reversed using prazosin (illustrated by *)
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Figure 23. Representative tracing illustrating the effects of glucopenia alone on the tone of 
precontracted tissue strips and the effects of reversing the conditions.
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Figure 24. Representative trace illustrating the effects of hypoxia and acidosis in 
combination on the tone of precontracted tissue strips and also the effects of reversing the 
conditions. At the end of the recovery period L-NAME and prazosin were added.
89
18413855
930 mins
2g
***"'........ 1 1 .....    » i.............................................
HYPOXIA AND GLUCOPENIA
Figure 25.  Representative trace illustrating the effects of hypoxia and glucopenia 
in combination on the tone of precontracted tissue strips and also the effects of 
reversing the conditions.
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Figure 26. Representative trace illustrating the effects of acidosis and 
glucopenia in combination on the tone of precontracted tissue and the effects 
of reversing the conditions.
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Figure 27. Representative trace illustrating the effects of hypoxia, acidosis and glucopenia 
in combination on the tone of precontracted tissue and the effects of reversing the 
conditions.
913.3.7  Cumulative  Concentration  Response  to  Phenylephrine  with  and  without 
Hypoxia, Acidosis and Glucopenia
In order to assess the change in sensitivity of the corpus cavernosum smooth 
muscle to adrenergic stimulation under ischaemic conditions, concentration response 
curves to phenylephrine were constructed before and after exposure to a combination 
of  hypoxia,  acidosis  and  glucopenia  for  4  hours.  Cumulative  addition  of 
phenylephrine  (0.1-300pM)  to  tissue  strips  in  normal  Krebs  solution  resulted  in  a 
contraction with EC50-  lOpM and a maximum tone of 3.1 ± 0.7g. Tissue strips were 
then washed and superfused in conditions of hypoxia, glucopenia and acidosis for a 4 
hour period which was followed by superfusion in normal Krebs solution. A further 
phenylephrine  concentration  response  experiment  gave  an  ECso~  3pM  and  a 
maximum  tone  of  0.9±0.2  g  which  were  both  significantly  different  from  that 
obtained in control tissue (p<0.05) (Figure 28).
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Figure 28: Phenylephrine concentration-response curves in control tissues which were superfused with 
normal Krebs  solution throughout the experiment (Control;  solid squares) and in tissues which were 
exposed to the combination of hypoxia, acidosis and glucopenia (H+A+G; open squares) for 4 hours 
and then superfused with normal Krebs solution. Each data point represents mean ± s.e. of mean of 4-6 
separate tissue strips from different animals.  *P<0.05  significantly different from control at the same 
concentration of phenylephrine.
3.3.8  Effect  of  Hypoxia,  Acidosis  and  Glucopenia  on  the  Tone  Elevated  by 
Endothelin-1 and U-46619
Experiments  were  repeated  by  pre-contracting  the  tissue  strips  with  either 
endothelin-1  (33.33nM) or U-46619(50nM) instead of phenylephrine. The tissue was 
superfused  in  conditions  of hypoxia,  acidosis  and  glucopenia  for  a  4  hour  period 
following which the conditions were reversed. Table  6   illustrates the minimum tone 
recorded  during  ischaemic  conditions  and  the  final  tone  recorded  following  the 
reversal of ischaemia.
93Minimum tone Reversal
Phenylephrine (n=10) 8.19±1.64 16.46±2.32
Endothelin-1 (n=4) 14.25±2.28 23.51±4.38
U-46619 (n=4) 22.48±3.04 28.38±2.68
Table 6. Comparison of the effects of hypoxia, acidosis and glucopenia on elevated tone and 
recovery using tissue precontracted with either phenylephrine, Endothelin-1  or U-46619.
3.3.9  Effect of Hypoxia, Acidosis and Glucopenia on Nitrergic Responses
EFS elicited reproducible and frequency-dependent relaxation responses after 
inhibition of noradrenergic and cholinergic pathways and elevation of the tone. These 
EFS-induced relaxation responses were completely inhibited with L-NAME (500 pM) 
or  TTX  (3pM)  (refer  Figure  22)  confirming  that  they  are  nitrergic  in  nature  and 
neuronal in origin. 4 hours of incubation with a combination of hypoxia, acidosis and 
glucopenia  reduced  the  tone  of the  strips  as  mentioned  above.  During  this  period 
nitrergic responses remained unchanged when expressed as the percentage of the tone 
(Figure  30).  Following  the  reversal  of hypoxia,  acidosis  or  glucopenia,  the  tone 
partially recovered and nitrergic relaxations appeared to be preserved (Figures 29 & 
30).
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Figure  29.  Representative  tracing  illustrating  EFS((50V,  0.3ms  pulse, 
frequency  0.5-50  Hz)  induced  nitrergic  relaxations  following  exposure  of 
tissue strips to 4 hours of hypoxia, acidosis and glucopenia in combination.
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Figure 30:  Nitrergic  relaxations  were  not affected by hypoxia,  acidosis  and  glucopenia.  Frequency- 
response curves of nitrergic relaxations expressed as the percentage of the maximum tone  in control 
tissues which were superfused with normal Krebs solution throughout the experiment (Control; solid 
squares) and  in tissues  which  were  exposed to the  combination of hypoxia,  acidosis  and glucopenia 
(H+A+G; open squares) for 4 hours and then superfused with normal Krebs solution. Each data point 
represents  mean ±  s.e.  of mean  of 10  separate tissue  strips from  5  different animals  for the control 
group and 22 tissue strips from 6 different animals for the experiments involving hypoxia,acidosis and 
glucopenia.
953.3.10  Investigation of Putative Therapeutic Agents
Several  putative  agents  were  tested  to  assess  their  potency  to  protect  the 
tissues against  irreversible tone  loss  in  ischemic conditions.  These agents  [calcium 
(3fxM-10pM),  Bay  K  8644  (direct  Ca2+  channel  activator,  lpM), N-acetylcysteine 
(anti-oxidant,  lOOpM),  N“-nitro-L-arginine  methyl  esther  (L-NAME,  NO  synthase 
inhibitor, 500pM), digoxin (Na/K ATPase inhibitor, lOpM) and glutathione (500pM)] 
were added to the reservoir after the combination of hypoxia, acidosis and glucopenia 
was  introduced.  The  agents  were  in  the  medium  after  normal  Krebs  solution  was 
introduced at the end of 4 hours. None of the agents altered the tone during 4 hours or 
after reversal of the conditions. As an example the effect of N-acetylcysteine is shown 
in Figure 31.  The effect of the agents at the initial tone and the reversal phase are 
shown in Table 7.
60 mins
Hypoxia + Acidosis + Glucopenia + N-acetylcysteine
Figure 31. The effects of adding N-acetylcysteine on corpus cavernosum smooth muscle 
tone  and  recovery  during  4  hours  superfusion  in  conditions  of hypoxia,  acidosis  and 
glucopenia. Total of 8 tissue strips from 4 separate animals.
96Putative Agent Minimum Tone Reversal
Hypoxia+Acidosis+Glucopenia 8.19±1.64 16.46±2.33
N-acetylcysteine 5.4±2.35 15.46±1.75
Bay K 8644 5.93±1.35 16.8±4.5
Glutathione 10.01±1.92 15.23±3.98
Digoxin 9.48±3.62 24.29±5.74
Calcium 8.03±3.49 31.7±9.06
L-NAME added t=0 11.67±2.12 13.58±1.9
L-NAME t=4 hours 16.44±3.09 18.63±3.11
Table  7.  The  effects  of putative  agents  on  corpus  cavernosum  smooth  muscle tone  during 4  hours 
superfusion in conditions of hypoxia, acidosis and glucopenia. Results expressed as a % of the initial 
tone.  All  results  represent  mean±SEM.  n=4  for  each  agent  (4-8  strips).  There  was  no  significant 
difference  in  the  recovery  of tissue  tone  in  the  presence  of putative  agents  compared  to  hypoxia, 
acidosis and glucopenia used in combination.
3.3.11  Experiments Utilising Metabolic Inhibition
In  order  to  assess  the  role  of oxidative  phosphorylation  and  glycolysis  in 
smooth  muscle  contraction  mechanisms,  experiments  were  repeated  using  500pM 
iodoacetic  acid  to  inhibit  glycolysis  or  500pM  myxothiazol  in  order  to  inhibit 
oxidative  phosphorylation.  Experiments  utilising  iodoacetic  acid  showed  a  rapid 
reduction  in  the  smooth  muscle  tone  to  the  baseline  within  30  minutes.  This  was 
completely irreversible (Figure 33). Myxothiazol showed a more gradual reduction in 
the tone to 20% of the initial tone and took up to 2 hours to reach this point (Figure 
32). Washout of myxothiazol resulted in a recovery of tone to 66% of the initial tone.
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Figure  32:  The  effects  of  adding  myxothiazol  on  smooth  muscle  tone.
EFS(50V,  0.3ms  pulse,  frequency  5Hz)  was  continued  throughout  the 
experimental period. For the purpose of clarity the points for EFS have not been 
illustrated.  Recovery  of  tone  following  the  washout  of  myxothiazol  is  also 
demonstrated.
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Figure  33:  The  effects  of adding  IAA  on  smooth  muscle  tone  and  recovery.  Tissue 
strips  were  precontracted  and  EFS  (50V,  0.3ms  pulse,  frequency  0.5Hz)  continued 
throughout the  perfusion period.  For the purpose  of clarity the  EFS  points  have not 
been illustrated. The lack of recovery of tone following the washout of iodoacetic acid 
is also demonstarated.
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^3.4  The measurement of ATP concentrations in the corpus cavernosum
In  order  to  investigate  the  effects  of ischaemic  conditions  on  tissue  ATP 
levels, the tissue ATP levels were measured at 4 time points:
•  Following the equilibration period
•  Following pre-contraction with phenylephrine
•  Following 4 hours superfusion with a combination of hypoxia,
acidosis and glucopenia
•  Following 1  hour reperfusion in normal Krebs solution.
A  typical  standard  curve  constructed  from  ATP  standards  is  illustrated  in 
Figure  34.  The  ATP  concentration  was  expressed  as  pmol/pg  protein.  The  results 
showed a significant reduction in ATP concentration following 4 hours incubation in 
conditions of hypoxia, acidosis and glucopenia. Tissue ATP failed to return to basal 
levels following the reintroduction of oxygen, normal pH and glucose (Table 8 ).
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Figure 34.  Example of a typical ATP standard curve.
99Time Point ATP concentration (pmol/pg)
Equilibration 60.2±9.3
Precontraction with phenylephrine 65.3±5.2
Following 4 hours hypoxia,acidosis and 
glucopenia
46.3±4.3*
Following reperfusion 48.7±2.4*
Table  8:  Changes  in  the  tissue  ATP  concentration  following  4  hours  superfusion  in  conditions  of 
hypoxia, acidosis and glucopenia followed by reversal. (* p<0.05)
3.5  Microscopic  changes  in  the  corpus  cavernosum  following  exposure  to 
hypoxia, acidosis and glucopenia in combination.
Histological analysis of the strips using H& E staining showed no significant 
change  in  the  smooth  muscle  and  endothelial  structures  after  incubation  with  a 
combination of hypoxia,  acidosis and glucopenia for 4  hours  (Figure  35).  However 
immunofluorescence studies showed a significant increase in the number of TUNEL- 
positive nuclei in the smooth muscle cells under these conditions.  Reperfusion with 
normal  Krebs  solution  failed  to  reverse  the  increase  in  TUNEL  staining.  Hypoxia 
alone caused an increase in TUNEL-positive nuclei although this was not to the same 
degree as that due to a combination of hypoxia, acidosis and glucopenia (Figure 36). 
Under control conditions less than 1% of smooth muscle cells were TUNEL-positive. 
TUNEL  positive-smooth  muscle  cells  were  66.5±2.5%  of the  total  smooth  muscle 
cells after 4 hours of hypoxia (P<0.05 vs control). After 4 hours of a combination of 
hypoxia, acidosis and glucopenia, this percentage was 88.6±6.9% (P<0.05 vs control 
and vs hypoxia). Reperfusion of the tissue with normal Krebs solution for 1  hour after
1004 hours of hypoxia,  acidosis and glucopenia did not alter the TUNEL staining (not 
shown).
3.6  Microscopic  Changes  in  Human  Corpus  Cavernosum  Following Prolonged 
Low-flow Priapism
TUNEL  staining was  also performed using human corpus cavernosum obtained 
from patients undergoing penectomy operations. This was compared to human corpus 
cavernosum obtained from a patient who presented with prolonged low-flow priapism 
and  showed a  significant  increase  in TUNEL-positive  smooth muscle  cells  (Figure 
37).
101(b)
Figure 35. Histological analysis of rabbit corpus cavernosum using H&E staining.  Magnification x250 
(a)  Control  tissue,  (b)  Corpus  cavernosum  following  4  hours  superfusion  in  conditions  of hypoxia, 
glucopenia and acidosis followed by immediate fixation in formalin.
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Figure 36.  Representative  pictures comparing TUNEL  staining of control  tissue  with tissue 
subjected to 4 hours of hypoxia or 4 hours hypoxia, acidosis and glucopenia.CONTROL
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Figure  37.  TUNEL  staining  of  normal  human  corpus  cavernosum  with  comparison  to  corpus 
cavernosum obtained from patients presenting with low-flow priapism.
104Chapter 4 
Discussion
4.1  Aims of the thesis
Low-flow priapism  is  a rare  medical  emergency  and therefore  very  limited 
research has been undertaken in order to understand the underlying pathophysiology 
leading to this condition. Even when medical interventions are successful in achieving 
penile detumescence, the incidence of long term erectile dysfunction is still reported 
at approximately 50% (8 6 ). Where patients have presented with a prolonged low-flow 
priapism,  successful  medical  intervention  either  using  pharmacological  agents  or 
surgical procedures are generally unrewarding leading to a high probability of erectile 
dysfunction in these individuals (8 6 ). In order to achieve full penile detumescence the 
smooth muscle contractile mechanisms must outweigh the effects of relaxation factors 
such  as  NO  and  prostaglandins.  The  contraction  of cavemosal  smooth  muscle  is 
altered  by  changes  in  the  local  smooth  muscle  microenvironment  (p0 2   and  pH) 
together with the availability of substrates (i.e.  glucose) required for glycolysis and 
oxidative  phosphorylation.  Although  the  effects  of  hypoxia  and  acidosis  on 
cavemosal  smooth  muscle  tone  have  been  investigated  both  in  vitro  and  in  vivo, 
(8 8 ; 144; 145) these studies have not investigated the effects of prolonged exposure to 
each of these  conditions  and  also  the  effects  upon the  recovery of smooth muscle 
tone.  In addition to  this,  the  effects  of glucopenia upon cavemosal  smooth muscle 
tone  and  recovery  of  tone  following  the  reversal  of  glucopenia  has  not  been 
investigated using in vitro models. The aim of this thesis was to investigate the factors 
which  cause  irreversible  smooth  muscle  dysfunction  in  low-flow  priapism.  By 
developing an in vitro model of low-flow priapism, I set out to investigate the effects
105of  prolonged  exposure  of  cavemosal  smooth  muscle  to  hypoxia,  acidosis  and 
glucopenia and also the capacity of this tissue to contract once these conditions were 
reversed.
4.2  General Discussion
In order to achieve penile detumescence, the contractile mechanisms in the 
corpus cavernosum must overcome the factors mediating relaxation. The development 
of stagnant ischaemia in a closed compartment such as the corpus cavernosum during 
a prolonged penile erection results in progressive hypoxia and acidosis. The analogy 
in an in vitro model would be that pre-contracted smooth muscle represents penile 
detumescence and a reduction in this basal tone represents smooth muscle relaxation 
corresponding to penile tumescence. By using such a model, I planned to investigate 
the effects of these conditions on smooth muscle tone using corpus cavernosum. My 
initial hypothesis was that the development of hypoxia per se would be the most 
important parameter involved in mediating irreversible smooth muscle dysfunction. 
Although exposure of smooth muscle strips to prolonged periods of hypoxia resulted 
in a reduction of the cavemosal smooth muscle tone, I found that the smooth muscle 
tone recovered well upon re-oxygenation.
The second hypothesis proposed that a combination of acidosis and hypoxia 
would  result  in  irreversible  recovery  of smooth  muscle  tone  following  prolonged 
periods of perfusion. Again I established that despite superfusing the tissue strips for 
continuous prolonged periods  of up to 48  hours,  on reversal  of these conditions to 
normoxia and pH 7.4, the smooth muscle tone would still recover to approximately 
20% of the  initial  tone.  In this  experiment the control  tissue  strips  demonstrated a
106progressive  reduction  in tone  as  the perfusion period  increased.  At the  end  of the 
perfusion period the tone of the control tissue strips was completely lost and there was 
no recovery of tone when the conditions were reversed back to normoxia and  pH 7.4.
In order to establish whether another common parameter exists in the corpus 
cavernosum  microenvironment  which  would  mediate  the  changes  of  irreversible 
smooth muscle dysfunction,  I studied the results of cavemosal blood aspirates from 
patients  who  presented  with prolonged  low-flow priapism  which  was  refractory to 
conventional treatments of corporal blood aspiration and instillation of a-adrenergic 
agonists.  From  the  results  obtained,  I  established  that  biochemical  analysis  of the 
aspirates  consistently  showed  the  presence  of either  a very  low  or  absent  glucose 
concentration coexisting with hypoxia and acidosis. Whether the irreversible nature of 
priapism is due to substrate depletion was still unknown. The effects of glucopenia on 
smooth muscle  tone  and  recovery  had  not been previously  investigated.  Therefore 
experiments were repeated to incorporate a shorter perfusion period to maintain the 
integrity of the control strips and also investigate the effects of substrate depletion on 
the smooth muscle tone and recovery following reversal of these conditions.  These 
experiments established that the two common parameters which mediate irreversible 
corpus  cavernosum  smooth  muscle  dysfunction  were  hypoxia  and  glucopenia  in 
combination.  I established that the degree of hypoxia and glucopenia in the corporal 
aspirates  was  a  better  predictor  for  smooth  muscle  recovery  in  individuals  who 
presented with prolonged episodes of priapism.
Although several putative agents have been proposed for the pharmacological 
management  of priapism  (146)  the  clinical  evidence  is  limited  and  therefore  the
107instillation  of a-adrenergic  agonists  remains the  most established treatment option. 
Therefore, I investigated the role of alternative pharmacological agents which could 
potentially  reduce  the  degree  of  irreversible  smooth  muscle  dysfunction.  I  had 
already confirmed that in conditions of hypoxia and acidosis, the cavemosal smooth 
muscle tone is significantly reduced in keeping with previous observations (8 8 ; 144). 
Glucopenia  was  also  found  to  reduce  the  smooth  muscle  tone.  These  components 
which  constitute  an  ischaemic  microenvironment  precipitate  smooth  muscle 
relaxation and hence prolong the penile tumescence. Thus in the clinical scenario, for 
a particular pharmacological agent to be efficacious, the degree of ischaemia present 
in  the  corpus  cavernosum  must  be  reduced.  Clinically  this  is  achieved  by  the 
technique of corporal blood aspiration.
I hypothesised that the irreversible recovery of smooth muscle tone following 
superfusion in ischaemic conditions may be due to the reduction in the availability for 
intracellular  Ca2+  required  for  smooth  muscle  contraction.  On  the  basis  of this 
hypothesis, pharmacotherapies were used to increase the intracellular Ca2+ levels by
1.  Increasing extracellular Ca2+  [Ca2+]e
2.  Direct activation of Ca2+ channels using the compound Bay K 8644
3.  Use of digoxin to inhibit Na+/K+ ATPase and therefore increase intracellular 
Ca2+ [Ca2+]i
None of these methods were effective in completely restoring the smooth muscle 
tone and so I hypothesised that there may be significant smooth muscle cell damage 
during tissue reperfusion which immediately follows the ischaemic period.  In the in 
vivo  situation  one  would  expect endogenous  antioxidants to  accumulate  during the
108period of stagnant ischaemia in the corpus cavernosum in order to prevent significant 
tissue  injury  during  the  reperfusion  period.  In  order  to  prevent  reperfusion  tissue 
injury, experiments were conducted in the presence of the antioxidant compounds N- 
acetylcysteine and glutathione. However, incubating the tissue strips in the presence 
of these compounds  throughout the  ischaemic period did not  significantly alter the 
degree of irreversible cavemosal smooth muscle dysfunction.
My final hypothesis was that the establishment of a hypoxic and glucopenic 
microenvironment in the corpus cavernosum would result in significant intracellular 
metabolic  inhibition  to  eventually  result  in  smooth  muscle  apoptosis.  Substrate 
depletion  during  the  period  of  hypoxia  and  glucopenia  would  inhibit  both  the 
oxidative  phosphorylation  pathway  and  the  glycolytic  pathway  necessary  for  the 
production  of  ATP.  Smooth  muscle  contraction  requires  the  generation  of  ATP 
predominantly from the oxidative phosphorylation pathway. ATP is also required for 
normal  cellular  homeostasis.  My  experiments  showed  that  in  the  presence  of 
ischaemia, the  tissue  ATP  levels were  significantly reduced.  Following reperfusion 
after 4 hours the tissue levels of ATP failed to recover back to basal cellular levels. 
Coinciding with this  irreversible  fall  in tissue  ATP  levels,  TUNEL  staining  of the 
cells  showed  irreversible  DNA  fragmentation  which  is  a marker  of cellular death. 
However,  the  histological  analysis  of  the  same  tissue  utilising  H&E  staining 
demonstrated  that  there  was  no  significant  morphological  difference  in  the  tissue 
before and after the period of ischaemia. In the long term cellular death is associated 
with the recruitment of inflammatory mediators and fibroblasts which ultimately lead 
to the replacement of myocytes with fibrous tissue. The disproportional replacement 
of  corpus  cavernosum  myocytes  which  would  normally  mediate  smooth  muscle
109relaxation  is  ultimately  responsible  for  the  development  of  long  term  erectile 
dysfunction.
4.3  The Characteristic Features of Patients Presenting with Low-flow Priapism
The  investigation  of patients  with  refractory  low-flow  priapism  is  the  first 
study to establish the common factor of glucopenia in the corporal blood aspirates of 
these patients.  It also confirmed the presence of significant hypoxia and acidosis in 
keeping with the previous study by Broderick and Harkaway (91).  Prolonged low- 
flow priapism results in the development of vascular stasis in a closed compartment. 
Therefore with prolonged stasis the utilisation of substrates such as glucose continues 
with  very  little  replenishment.  The  intracellular  stores  of  glycogen  can  be  an 
additional source of substrate for glycolysis in order to maintain cellular homeostasis 
during periods of hypoxia.  The failure of replenishment of these intracellular stores 
results in the progressive development of glucopenia.
Doppler studies are utilised as a diagnostic radiological investigation in order 
to differentiate between a high-flow priapism and low-flow priapism.  Although my 
series  of patients  clinically  presented  with  a  low-flow priapism,  confirmed  by the 
results of corpus cavernosum aspirations, there were two cases whereby the Doppler 
studies  suggested  a high-flow picture.  The  use  of Doppler  studies  are  not  entirely 
specific  for  a  diagnosis  of  low-flow  priapism  as  the  Doppler  picture  can  be 
misinterpreted  following  multiple  cavernous  needle  aspirations  or  shunt  surgery 
which may result in local areas of cavemosal reperfusion despite the overall picture 
remaining as one  of a low-flow priapism.  Therefore the results of Doppler studies 
must be used with caution as false negative results are also possible.
110The effects of high dose phenylephrine on tissue strips from priapic patients 
were  compared  with  the  effects  on  strips  obtained  from  penile  cancer  patients. 
Although the phallus in penile cancer patients is pathological, all the tumours were 
confined distally and the pre-operative erectile  function was preserved.  Therefore I 
conducted this study with the assumption that these tissue strips are representative of 
normal  corpus  cavernosum.  An  alternative  source  of tissue  obtained  from patients 
undergoing gender reassignment surgery showed that the EC50 was comparable to that 
of tissue obtained from my series of penile cancer patients (154).
Histological  analysis  conducted by the  UCLH histopathology department of 
tissue  biopsied  from  patients  presenting  with  refractory  low-flow  priapism 
demonstrated  changes  in  the  intracellular  organelles  which  would  be  incompatible 
with cellular viability. These tissue strips were reperfused in vitro. Upon reperfusion 
in  normoxic  conditions,  there  was  still  a  complete  failure  of  smooth  muscle 
contraction to high doses of phenylephrine. Subsequent TUNEL staining of this tissue 
confirmed  the  presence  of  widespread  cellular  death.  Therefore  in  this  clinical 
situation  the  duration  of priapism  is  perceived  as  being  sufficiently  prolonged  to 
induce cell death in the corpus cavernosum. The eventual long term sequel would be 
that inflammatory  cells  and  fibroblast  recruitment  into  the  tissue  leads  to  corporal 
fibrosis which ultimately leads to erectile dysfunction.
4.4  The Factors Involved in Cavemosal Smooth Muscle Dysfunction.
An in vitro model of ischaemic priapism was developed in order to reproduce 
the clinical scenario and investigate the factors which are responsible for reducing the 
corporal smooth muscle tone and mediating irreversible smooth muscle dysfunction.
IllTissue  strips  were  pre-contracted  with  phenylephrine  as  we  know  that  penile 
flaccidity is maintained by a tonic sympathetic discharge.
4.4.1  The Effect of Hypoxia on Cavemosal Smooth Muscle Tone
I established that hypoxia alone reduced the smooth muscle tone in keeping 
with previous studies (8 8 ; 144). However, upon re-oxygenation, the cavemosal smooth 
muscle  tone  recovered  completely.  This  is  the  first  in  vitro  study  which  has 
investigated  the  effects  of  re-oxygenation  following  prolonged  hypoxia  on  the 
recovery of corporal  smooth muscle function.  The findings  suggested that although 
the development of hypoxia during priapism may have a role in maintaining penile 
tumescence by causing smooth muscle relaxation, hypoxia alone can not account for 
the irreversible smooth muscle dysfunction.
My  initial  experimental  studies  showed  that  the  control  tissue  strips 
progressively lost smooth muscle tone to almost unrecordable levels as the duration of 
the perfusion period increased upto 48 hours. This phenomenon was irreversible and 
occurred  well  within  the  48  hour  period,  normally  between  16  to  20  hours.  As 
carbogen  was  used  which  is  a  mixture  of 95%  O2  and  5%  CO2  in  the  perfusion 
medium this may have resulted in oxidative stress.  The formation of NO2, NO’ and 
ONOO’ in the presence of O2 is known to cause tissue injury (155). Therefore in order 
to  allow  a  valid  comparison  between  the  control  and  experimental  tissues,  the 
perfusion  periods  were  reduced  to  4  hours  so  that  the  control  tissue  maintained 
smooth muscle tone throughout the complete experimental period. It is unlikely that 
the  progressive  reduction  in  the  tone  was  due  to  the  induction  of  iNOS  as  all 
experiments  were  performed  in  the  presence  of dexamethasone  to  prevent  iNOS
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found that the smooth muscle tone of the control tissue progressively declined with 
time.
Experiments utilising the  shorter perfusion periods demonstrated that all the 
parameters  namely  hypoxia,  acidosis  and  glucopenia reduced  the  corporal  smooth 
muscle  tone  either  alone  or  in  combination  with the  greatest  magnitude  occurring 
when hypoxia and glucopenia were used in combination. Although acidosis reduced 
tone,  this  was  not  as  significant  as  when  the  other  parameters  were  investigated 
individually.  When  acidosis was used in combination with hypoxia, the percentage 
recovery of smooth muscle tone was better than if hypoxia was used in isolation. This 
suggests  that the  presence  of acidosis  in  a hypoxic  microenvironment  may have  a 
protective effect on the corpus cavernosum smooth muscle. A possible explanation for 
this  phenomenon  is  given  later  when  I  discuss  the  effects  of acidosis  on  smooth 
muscle tone.
In the presence of hypoxia alone, the tone of the cavemosal smooth muscle is 
decreased.  This  confirms  the  findings  from  previous  studies  (8 8 ; 144).  During  the 
perfusion  period  which  utilized  only  hypoxic  conditions,  the  reduced  tone  was 
sustained.  When  the  hypoxia  was  reversed,  the  tissue  regained  the  original  tone 
indicating  that  hypoxia  alone  does  not  result  in  irreversible  smooth  muscle 
dysfunction.  Only  one  previous  study  has  demonstrated  a  similar  finding  using 
hypoxia  alone.  However  the  perfusion  period  in  this  study  was  restricted  to  a 
maximum of 2.5 hours (8 8 ). The purpose of my in vitro model was to investigate the 
changes  in  smooth  muscle  tone  occurring  in  prolonged  low-flow  priapism  and
113therefore progressively longer perfusion periods were employed. The contraction of 
cavemosal smooth muscle depends on the mobilisation of Ca2+ from the sarcoplasmic 
reticulum  and  also  the  transmembrane  Ca2+  influx.  One  would  expect  that  the 
reduction  in  the  [Ca2+]j  results  in  smooth  muscle  relaxation  by  MLC20 
dephosphorylation.  However,  studies  on  alternative  smooth  muscle  sources  have 
shown that relaxation in the presence of hypoxia, the  [Ca2+]j may increase in ileum 
(157), aorta (158), portal vein (159) and pulmonary tissue (160). The [Ca2+]j has been 
shown to remain unaltered in cerebral (161) and taenia coli (162) despite concurrent 
smooth muscle relaxation. Therefore the smooth muscle relaxation due to hypoxia is 
likely  to  be  multifactorial.  Kim  et  al  (8 8 )  demonstrated  that  the  [Ca2+]j  levels 
increased during hypoxia by loading the tissue with the intracellular fluorescent dye 
FURA-2.  When tissue strips were exposed to hypoxic buffer in this study, there was 
a transient  decrease  in  the  [Ca2+]j  which  was  followed  by  a  large  increase  in  the 
[Ca2+]j within 4 minutes of exposure to hypoxia.  This study suggests that there is a 
dissociation  between  the  [Ca2+]j  levels  and  generation  of force  during  hypoxia. 
However, the Ca2+ transients which rely on calcium influx through Ca2+ channels are 
reduced during hypoxia (163). This may be secondary to the direct effect of hypoxia 
on oxygen sensitive Ca2+ channels, a reduction in the ATP concentration or the raised 
[Ca2+]j inhibiting the channel directly. Therefore hypoxia-induced loss of tone may be 
secondary to the altered sensitivity of the contractile apparatus to intracellular Ca2+ as 
well  as  a  reduction  in  the  Ca2+  transient.  Alternatively  the  contractile  apparatus 
becomes unresponsive to increased Ca2+ levels due to a reduction in the intracellular 
ATP levels. The reduction in cytosolic ATP may reduce the MLC20 phosphorylation 
and  account  for the  reduction  in tone.  However,  previous  studies have  shown that
114there are no  significant changes  in the MLC20 phosphorylation during hypoxia and 
therefore this alone is unlikely to account for the reduction in force (164).
The discussion so far has failed to convincingly show that there is a straight 
forward relationship of [Ca2+]j -force or MLC2o-force. Alternative pathways of force 
reduction  during  hypoxia  must  account  for  the  observations.  Another  possible 
pathway  involves  the  ATP-gated  K +  channels present in  smooth muscle  (K atp).  A 
number of studies  have  proposed that  this  channel  is  involved  in the  dilatation  of 
coronary and cerebral arterioles during hypoxia (165-167). This channel is inhibited 
by  intracellular  ATP  and  therefore  during  hypoxia  the  fall  in  cytosolic  ATP  and 
decrease in intracellular pH will lead to the opening of this channel and subsequent 
hyperpolarisation  and  smooth  muscle  relaxation.  Although  the  K atp  channel  may 
have  a  partial  contribution  to  the  hypoxia-induced  relaxation,  some  studies  have 
shown  that  hypoxia  produces  a  small  membrane  depolarisation  rather  than  a 
hyperpolarisation (168; 169). The K atp channel blocker, glibenclamide, is also unable 
to reverse the effects of hypoxia in these studies (170). Therefore it is unlikely that the 
effects  of hypoxia on  force  are  solely  mediated by the  depolarisation  due to  K atp 
channel opening.
Hypoxia has  been  shown to  induce  elevations  of inorganic phosphate,  [Pi],
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both in vivo and in vitro (164; 171). Pi inhibits Ca  activated force of permeabilised 
smooth  muscle  fibres  (172).  This  occurs  independently  of MLC20  phosphorylation 
(173; 174). Therefore the increase in [Pi] may partly account for the reduction in force 
during  hypoxia  without  altering  MLC20  phosphorylation.  Studies  have  reduced  the 
increases in [Pi] during altered metabolism and found that the rates of relaxation and
115inhibition of force were also less (164). However, the increase in [Pi] alone can not 
account  for  the  reduced  tone  during  hypoxia  or  metabolic  inhibition.  Therefore, 
changes  in  [Pi]  may  partly  explain the  change  in  smooth muscle  tone  seen  in my 
experiments but the overall contribution is still uncertain.
Another mechanism which may partly account for the effects of hypoxia and 
metabolic  inhibition  is  the  activation of Ca2+  dependent  actin-capping proteins  and 
proteases  (175).  These  have  been  suggested  to  contribute  to  attenuated  cardiac 
contractility following ischaemic reperfusion (176). The actin capping agents inhibit
^   I
tonic smooth muscle contraction independently of [Ca  ] and MLC20 phosphorylation 
(177; 178). The extent of this inhibition of force is similar to that observed in studies 
utilising mitochondrial  inhibition (179).  Therefore it appears that in the presence of 
hypoxia, the reduction in oxidative phosphorylation combined with a reduction in the 
Ca2+ transients independent of cytosolic  Ca2+ levels together with elevated  [Pi]  and 
changes in the cytoskeleton account for the smooth muscle relaxation. Finally, the fall 
in ATP levels within the smooth muscle cells during hypoxia would be expected to 
reduce  myosin  ATPase  activity  and  reduce  phosphorylation  of MLC20.  However, 
several studies have proposed that in the presence of hypoxia alone, the change in the 
ATP  levels  surrounding  the  myofilaments  is  unlikely to  limit myosin  ATPase  and 
hence  contraction  (171; 180).  The  fact  that  the  smooth  muscle  tone  recovered 
following reoxygenation and that the TUNEL staining experiments showed very little 
in  the  way  of  smooth  muscle  cell  death  indicates  that  the  ATP  levels  were  not 
significantly depleted enough to result in significant smooth muscle cell death.
116The effects of hypoxia were found to be reversible as the re-introduction of 
oxygen resulted in a complete recovery of the smooth muscle tone. This suggests that 
the  corpus  cavernosum  is  highly  dependent  on  energy  yields  from  oxidative 
phosphorylation  but  can  still  function  in  variable  degrees  of  hypoxia  without 
undergoing  permanent  smooth  muscle  dysfunction.  This  would  of  course  be  an 
important consideration bearing in mind the wide range of p(> 2 levels that the human 
corpus cavernosum is subjected to in the stages from flaccidity to full tumescence.
4.4.2  The Effect of Acidosis on Cavernosal Smooth Muscle Function
Although  it  is  postulated  that  alterations  in  pH  alone  can  induce  cellular 
injury, our experiments investigating the role of acidosis alone showed that the loss in 
smooth muscle tone is not of the same magnitude compared to when hypoxia is used 
alone.  Reversing the pH back to pH 7.4 did not result in significant smooth muscle 
dysfunction. This is the first study which has demonstrated that prolonged exposure to 
acidosis  alone  does  not  result  in  irreversible  corporal  smooth  muscle  dysfunction. 
Previous  studies  have  investigated  the  effects  of acidosis  on  smooth  muscle  tone 
without  looking  at  the  effects  of  reversing  the  pH  back  to  physiological  levels 
(145;151). My findings also confirmed that superfusion of corpus cavernosum tissue 
strips  in  acidotic  conditions  results  in  a  reduction  in  the  smooth  muscle  tone  in 
keeping with previous studies (145; 151).
My experiments reduced the pH to 6.9 by reducing the HCO3 content of the 
Krebs solution as described by Ralevic (181). An alternative technique involves the 
use  of 10%  CO2  mixtures  and  is  proposed to reduce  intracellular pH(pHj)  directly
117(182). Although our technique alters extracellular pH(pH0), studies have shown that a 
unit change in the pH0 induces a ratio of 0.73 change in pHj (183). The reduction in 
the  smooth muscle  tone  following  acidification  shows that the  corpus  cavernosum 
behaves  similarly  to  other  vascular  smooth  muscle  as  similar  findings  have  been 
shown in rat mesenteric smooth muscle (183), rat aorta (184) and rat cerebral artery 
(185). The pH0 induced change in the tone may be accounted for by changes in the 
[Ca2+] j. The modulation of [Ca2+]j by changes in the pH may be a result of the direct 
effects  on  ion  channels,  Ca2+  stores  or  Ca2+ pumps.  Previous  studies  on  different 
smooth muscle have shown that a reduction in the pHj reduces Ca2+ influx through L- 
type voltage activated Ca2+channels (186; 187). The effect may be mediated by the p- 
2a subunit of the channel which activates or deactivates the L-type channel according 
to the degree of protonation or deprotonation (187).  The  effects of changes in pH0 
may be due to the transduction changes in the pH* although direct effects of pH0 on 
the L-type Ca2+ channel conductance have also been postulated (188). Although the 
effects  on  T-type  channels  has  not  been  extensively  studied  in  smooth  muscle,  in 
cardiac cells pH0 had similar effects on the T-type channel as those seen in the L-type 
Ca2+channel although the T-type channel was insensitive to changes in pH* (189). The 
effects of pH changes on smooth muscle tone may also affect the release of Ca2+ from 
intracellular  stores.  Although  in phasic  smooth muscle  such as the portal  vein, the 
main  source  of  Ca2+  is  from  extracellular  influx,  in  tonic  smooth  muscle  the 
intracellular stores play a more important role and these tissues are more dependent 
on agonist induced Ca2+ release. The Ca2+ release from these stores can occur via Ca2+ 
induced  Ca2+  release  (CICR)  from  the  sarcoplasmic  reticulum  or IP3  induced  Ca2+ 
release.
118The influx of Ca2+ through Ca2+ channels is the trigger for CICR. Studies on 
vascular  smooth  muscle  have  demonstrated that both acidification or alkalinisation
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can release Ca  from the sarcoplasmic reticulum although the effects of acidification 
are less (190). Therefore the effects of acidosis on reducing the smooth muscle tone 
are  not  necessarily  due  to  a  direct  reduction  in  the  CICR  from  the  sarcoplasmic 
reticulum.  However  IP3-induced  release  of Ca  is  also  pH  sensitive  and  could be 
modulated by  either modulation of IP3  to  its binding site  or modulation of the  IP3 
sensitive release channel. Studies on alternative tissue have shown the pH dependence 
of nVinduced Ca2+ release (191; 192). A further mechanism involves changes in the 
sensitivity of the contractile machinery in the absence of changes in the [Ca  ]\. The 
mechanism  by  which  this  may  occur  includes  modulation  of myosin  light  chain 
kinase,  myosin  light-chain  phosphatase  and  Rho  kinase.  Finally  the  role  of the 
sarcoplamic reticulum Ca2+ ATPase which refills the Ca2+ store after CICR and the 
plasma membrane Ca2+ ATPase which maintains resting  [Ca2+]j have not been fully 
evaluated  in  smooth  muscle.  In  my  model  I  found  that  the  magnitude  of  the 
contribution to the overall reduction in tone induced by alterations in the pH0 is not as 
great  as  the  effects  of hypoxia.  I  found  that  the  minimum  sustained  tone  during 
perfusion with acidified Krebs solution was only reduced to 60% of the initial tone. 
Therefore,  although  acidosis  reduces  the  smooth  muscle  tone,  the  underlying 
mechanism is likely to be different to that of hypoxia.
A combination of hypoxia with acidosis again showed a reduction in smooth 
muscle tone which was sustained throughout the perfusion period in these conditions. 
These findings confirm those of previous studies (151). Again the prolonged periods 
of perfusion up to 48 hours were not conclusive due to the spontaneous loss of tone in
119the control tissue.  Once the perfusion period had been shortened the results showed 
that  on  reversal  of both  hypoxia  and  acidosis,  the  smooth  muscle  tone  not  only 
recovered but  actually  increased  compared  to  control  tissue.  Although  there  was  a 
gradual loss in tone of the control tissue, the recovery to  1 0 0 % of the initial tone of 
tissue strips suggested a protective role for an acidotic microenvironment. Although 
acidosis does not prevent ATP depletion during ischaemia(193;194), the acidotic pH 
suppresses  degradative  enzymes  activated  by  hypoxia  such  as  phospholipases  and 
proteases  (195).  This  affords  cytoprotection  and  delays  cellular death in ischaemia 
reperfusion conditions (196) This phenomenon has been reported in rat hepatocytes 
using both intracellular and extracellular acidosis (194; 197).
The initial experiments did not establish the underlying mechanism mediating 
irreversible  smooth  muscle  dysfunction.  However,  our  analysis  of corporal  blood 
aspirations did provide further data which has not been previously reported. Patients 
presenting with a failure of detumescence were consistently found to have very low 
levels or no glucose present in the corporal blood aspirates in addition to hypoxia and 
acidosis.  Whether glucopenia per se is responsible for irreversible corporal  smooth 
muscle dysfunction has not been previously investigated.
4.5  The Use of In Vitro Models of Ischaemia to Investigate Low-flow Priapism.
As  prolonged  ischaemic  priapism  establishes  a  closed  system  of  blood 
engorgement, substrate utilisation would expect to reduce the availability of glucose 
for normal  cellular metabolism.  In vitro models of ischaemia have utilized hypoxia 
and glucopenia in combination to reproduce the conditions  (198; 199).  As yet there 
have  been  no  similar  studies  investigating  the  effects  of glucopenia per  se  on the
120corpus  cavernosum.  Whether  this  would  have  a  significantly  greater  bearing  on 
reducing corporal smooth muscle tone and the subsequent recovery of smooth muscle 
tone would  be  important  in the  management  of patients  with prolonged  ischaemic 
priapism.
Our  investigations  showed that  glucopenia reduces  corporal  smooth muscle 
tone although the time period taken in order to reach the minimum sustained tone was 
much longer compared to  experiments utilising hypoxia alone.  This would suggest 
that significant stores of glycogen are present in the corporal smooth muscle cells in 
order  to  maintain  cellular  homeostasis.  On  the  reintroduction  of glucose,  smooth 
muscle tone recovers fully. Therefore extracellular glucose has a role in maintaining 
smooth  muscle  contractility.  Intracellular  stores  of  glycogen  can  maintain  cell 
homeostasis but are  inadequate to  maintain smooth muscle contraction.  This  is the 
first study which has investigated the effects of glucopenia on corporal smooth muscle 
contraction.  However, this still did not explain the basis for the irreversible smooth 
muscle dysfunction.
When hypoxia and  glucopenia were  combined,  the  corporal  smooth muscle 
tone was reduced to 23% of the initial tone. The minimum tone recorded was lower 
than that for all the other combinations except when hypoxia, acidosis and glucopenia 
were combined.  When the conditions were reversed, the cavemosal  smooth muscle 
only partially  recovered the  contractile  function.  This  indicates  irreversible  smooth 
muscle recovery in these conditions.  Similar work utilising guinea pig bladder also 
demonstrated  a  greater  rate  of  contractile  failure  in  conditions  of  hypoxia  and 
glucopenia compared to hypoxia alone (198).  Combining hypoxia and glucopenia is
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variety  of tissue  types  and  locations.  This  combination  was  found to  be  the  most 
important  in  mediating  irreversible  smooth  muscle  dysfunction.  It  indicates  that 
oxidative  glucose  metabolism  is  of central  importance  in  maintaining  the  smooth 
muscle contraction.
The  effects  of glucopenia  alone  showed  that  glucose  deprivation  does  not 
induce irreversible smooth muscle dysfunction. During the four hour period, oxidative 
phosphorylation  utilises  stored  glycogen  and  maintains  cellular  homeostasis  with 
good recovery of tone upon the reintroduction of glucose. Therefore both parameters 
of hypoxia  and  glucopenia  must  coexist  in  order  to  mediate  irreversible  smooth 
muscle dysfunction.  When all three parameters coexist, the presence of acidosis no 
longer offers protection to ischaemic damage. There is still irreversible recovery with 
the smooth muscle recovering to 16% of the initial tone.
In order to ascertain whether this phenomenon was due to a conformational 
change  in  the  phenylephrine/a  receptor  interaction  at  the  cell  membrane  level, 
alternative  agents  were  used  to  pre-contract  the  tissue  strips.  Our results  using  U- 
46619  and  endothelin-1  which  both  utilise  the  IP3  second  messenger  intracellular 
pathway,  showed  that  the  phenomenon  of  irreversible  recovery  was  mediated 
intracellularly.  Therefore when applied to the clinical picture of low-flow priapism, 
we can say that in the presence of hypoxia and glucopenia failure of detumescence 
following  drainage  and  a  agonist  instillation  signifies  irreversible  smooth  muscle 
dysfunction.
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In an attempt to accurately mimic the conditions occurring in refractory low- 
flow  priapism,  a  model  representing  irreversible  smooth  muscle  dysfunction  was 
developed in order to investigate the role of potential pharmacotherapies which may 
have a therapeutic role in preventing irreversible smooth muscle dysfunction which 
would manifest in the long term as erectile dysfunction. Clinical observations in this 
study have shown that conventional a agonist instillation into the corpus cavernosum 
of patients with prolonged low-flow priapism has limited efficacy. By utilising my in 
vitro  model  of  low-flow  priapism  with  irreversible  smooth  muscle  dysfunction, 
potentially  novel  therapeutic  options  were  evaluated.  The  main  objective  of these 
agents  was  to  try  and  limit  the  smooth  muscle  dysfunction  which  followed  the 
ischaemic period.
4.6.1  The Effect of NO Synthase Inhibition on Smooth Muscle Recovery
Nitric oxide is the most important mediator of smooth muscle relaxation in the 
corpus cavernosum during penile erection.  Whether NO was  involved in mediating 
the  loss  of smooth  muscle  tone  in  my  model  was  investigated  by  adding the NO 
synthase inhibitor L-NAME to the superfusate. When L-NAME was added at the end 
of the ischaemic perfusion period and the ischaemic conditions reversed, there was no 
significant  recovery  of smooth  muscle  function.  This  indicated  that  the  failure  of 
recovery  was  not  mediated  by NO.  When  L-NAME  was  added  at the  start  of the 
ischemic  perfusion  period,  the  EFS  induced  nitrergic  relaxations  were  abolished. 
However, corporal smooth muscle tone continued to fall at the same rate and to the 
same minimum  sustained tone as when ischaemic conditions were utilised on their 
own. This indicates that the reduction in smooth muscle tone during ischaemia is not
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investigated the role of NO in mediating the effects of hypoxia on corpus cavemosum 
(200).  This  in  vivo  study  used  anaesthetised  cats and measured the  intracavemosal 
pressure (ICP) in conditions of normoxia and hypoxia. Although there was no change 
in the ICP when conditions were changed from normoxia to hypoxia, the responses to 
L-arginine,  S-nitroso-N-acetyl-penicillamine  (SNAP)  which  is  a NO  donor  showed 
that  the  increase  in  ICP  seen  during  normoxic  conditions  were  attenuated  during 
hypoxia.  This  study  confirmed  that  during  normoxia  cavemosal  smooth  muscle 
relaxation  is  mediated  by  NO.  However  this  effect  is  abolished  in  conditions  of 
definitive  hypoxia  (pO2<30mmHg).  Therefore  in  keeping  with  the  findings  of my 
experiments whereby L-NAME failed to prevent the loss of smooth muscle tone in 
ischaemic  conditions  and  failed to  reverse the  smooth  muscle  dysfunction,  we can 
conclude that the NO  pathway  does  not significantly  contribute to the  loss of tone 
during prolonged low-flow priapism. Following on from this, NO inhibition does not 
provide a potential pharmacotherapeutic route to reverse low-flow priapism or prevent 
irreversible smooth muscle dysfunction.  Although the NO pathway may not have a 
role in sustaining the penile erection during prolonged priapism, it may still have a 
role in initiating the condition. This area requires further research and investigation.
4.6.2  The  Use  of  Antioxidants  in  Preventing  Irreversible  Smooth  Muscle 
Dysfunction
Ischaemia  followed  by  reperfusion  is  known  to  generate  free  radicals  and 
cause tissue injury (see section 1.4.3). We postulated that the reperfusion of the tissue 
strips  following  four hours of ischaemia may cause a significant reperfusion tissue 
injury and mediate the subsequent failure of smooth muscle contraction. By using the
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means of cytoprotection we found no significant recovery of smooth muscle function 
when ischaemia was reversed after 4 hours.
Glutathione  is  a  free  radical  scavenger  and  therefore  I  proposed  that  the 
reduction in free radical generation on reperfusion of ischaemic corporal tissue may 
result  in  a  reduction  in  the  smooth  muscle  dysfunction  by  preventing  reperfusion 
injury.  However,  my  experiments  utilising  glutathione  again  showed no  significant 
cytoprotection for the corpus cavemosum smooth muscle.  Therefore the use of free 
radical scavengers in prolonged ischaemic priapism is unlikely to prevent cavemosal 
tissue injury and subsequent long term erectile dysfunction.
One previous study has investigated the physiologic and biochemical changes 
which occur during reperfusion of ischaemic tissue (146). In this study, rabbit pelvic 
nerves were stimulated to induce a penile erection followed by clamping of the penis 
to induce  ischaemia.  On reperfusion the researchers  found  a significant increase in 
myeloperoxidase activity and lipid peroxidation which indicate oxidative stress. It is 
likely that  during the  stage  of reoxygenation the univalent reductions of molecular 
oxygen to superoxide anion, hydrogen peroxide and hydroxyl radical occurs (201). It 
has  also  been  proposed  that  the  reaction  of NO  with  superoxide  radicals  forming 
peroxynitrite generates more hydroxyl radicals (202).  However, we have previously 
shown  that  the  NO  pathway  may  have  very  little  role  during  prolonged  low-flow 
priapism and therefore peroxynitrite generation is unlikely to contribute significantly. 
Even so, the generation of ROS can lead to significant tissue injury as demonstrated 
in other organs such as cardiac muscle and intestinal tissue (201). Specifically in the
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hypoxia-reperfusion  injury  (84;203;204).  The presence  of a ROS  scavenger during 
reoxygenation has been shown to increase prostanoid production more quickly (204). 
This was part of the basis for using glutathione in my experiments. However, both N- 
acetylcysteine  and  glutathione  failed  to  prevent  smooth  muscle  dysfunction  in my 
experimental set up. Alternative agents such as allopurinol may have a role. Previous 
work  has  shown  that  allopurinol  inhibits  the  generation  of free  radicals  and  has 
previously been shown to reduce lipid peroxidation in corpus cavemosum (152).
4.6.3  The Use of Digoxin to Reverse Cavernosal Smooth Muscle Relaxation.
Digoxin is a cardiac glycoside associated with erectile dysfunction thought to 
be  mediated  via  the  inhibition  of  the  sodium  pump  in  the  corpus  cavemosum 
(135;136). Previous work has shown that digoxin at high concentration (lpM) causes 
contraction  of human  corpus  cavemosum  (135).  This  has  formed the  basis  for the 
potential use of digoxin in stuttering priapism although there have been no reports of 
the potential use of digoxin in acute low-flow priapism. Therefore in my experiments 
I investigated the effects of a high concentration of digoxin (IOjjM) in order to reverse 
the  smooth muscle  relaxation  induced by  ischaemia.  The results  showed that there 
was  no  significant  increase  in  the  smooth  muscle  recovery  following  four  hours 
ischaemia.  Digoxin  is  a Na+/K+ ATPase  inhibitor which increases  the  intracellular 
Ca2+  concentration.  In  cardiac  myocytes  this  leads  to  a  positive  inotropic  effect. 
However, despite one previous study reporting digoxin-mediated cavernosal smooth 
muscle  contraction,  my  study  failed  to  elicit  a  potential  role  in  reversing  smooth 
muscle dysfunction. The study by Gupta et al (136) utilised the NO donor S-nitroso- 
glutathione to induce smooth muscle relaxation which was subsequently inhibited by
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relaxation in my model was not mediated by the NO pathway. Therefore digoxin may 
have  a  role  in  preventing  NO-mediated  smooth  muscle  relaxation  as  opposed  to 
smooth muscle relaxation induced by ischaemia.
4.6.4 Modulation of Intracellular Ca2+ levels
The final set of experiments involved altering the intracellular Ca2+ levels by 
using  the  direct  L-type  Ca2+  channel  opener  Bay  K  8644  or  by  elevating  the
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extracellular  Ca  levels.  Previous  studies  using  bronchial  rings  have  shown  that 
hypoxia-induced relaxation of pre-contracted smooth muscle is prevented by the use 
of Bay K 8644 (205). Herrara and Walker concluded that hypoxia induced relaxation 
of vascular smooth muscle was due to  inhibition of L-type  Ca2+ channels by using 
Bay K 8644 to pre-contract the tissue (206). Therefore I proposed that using the direct 
Ca2+  channel  activator,  Bay  K  8644,  I  may  be  able  to  reverse  the  smooth muscle 
relaxation induced by ischaemia. I found that following the ischaemic period of tissue 
perfusion, Bay K 8644 did not significantly increase smooth muscle tone. This is the 
first  study  which  has  utilised  this  compound  in  order  to  reverse  the  effects  of 
ischaemia on corpus  cavemosum smooth muscle.  The failure of Ca2+ influx via L- 
Type channels to increase the corpus cavemosum smooth muscle tone suggests that 
Ca2+  transients  do  not  have  a  significant  role  in  modulating  smooth  muscle  tone 
following prolonged  ischaemia.  Increasing the extracellular Ca  concentration did 
however increase the smooth muscle tone following the period of ischaemia but the 
recovery was incomplete. There has only been one previous study utilising guinea pig 
taenia coli which has also shown that an increase in the extracellular Ca2+ levels can
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(207).
The  increase  in  Ca2+  levels  may result  in changes  in the  Ca2+ transients or 
increase  CICR  from  alternative  intracellular  Ca2+  stores.  As  there  is  conflicting 
evidence on changes in the cytosolic Ca  levels in response to hypoxia depending on 
the tissue type utilised in the study, further work is required to quantify the changes in 
the intracellular Ca  levels in response to ischaemia. Up until now there is only one 
study which has specifically investigated the changes in the intracellular Ca2+ levels in 
response to hypoxia (8 8 ). This study found that in corpus cavemosum the intracellular 
Ca2+ increased  in response to  hypoxia.  However,  the experiments utilised FURA-2 
loaded tissue as opposed to single cells which would be a more accurate measure of 
the changes in the Ca2+ levels. The small increase in smooth muscle tone in response 
to increasing the extracellular Ca2+ levels may provide a potential therapeutic option 
in low-flow priapism which is unresponsive to conventional treatments.
4.7  The Preservation of NO-Mediated Nitrergic Relaxations
The initial experiments using a perfusion period of up to 48 hours showed that 
although the smooth muscle tone gradually diminished  with time,  the EFS-induced 
nitrergic relaxations appeared to be preserved. Experiments using 4 hours exposure to 
conditions of hypoxia, glucopenia and acidosis in combination, showed that the EFS- 
induced nitrergic relaxations were in deed preserved. Previous studies have reported a 
similar  phenomenon  using  bladder  detrusor  muscle  suggesting  that  although  the
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preserved (198).
The  role  of NO  in  ischaemia-reperfusion  remains  controversial.  Although 
there  have  been  no  previous  studies  investigating  the  preservation  of  nitrergic 
pathways  in  corpus  cavemosum  following  ischaemia,  investigators  have  utilised 
cardiac myocytes to investigate whether NO is cytoprotective or detrimental (208). As 
already  stated,  the  interaction  of NO  with  superoxide  results  in  the  formation  of 
peroxynitrite  which  is  considered  cytotoxic  in  high  concentrations  in  ischaemia- 
reperfusion  injury  (209;210).  However,  NO  may  also  offer  cytoprotection  by 
scavenging superoxide anions (155) or by inhibiting apoptosis (211).
The cysteine protease family of caspases plays an important role in the signal 
transduction  during  apoptosis.  The  caspase  3  subfamily  (caspase-3,-6  and  -7)  are 
involved in the effector phase of apoptosis.  Previous work has shown that NO may 
arrest  apoptosis  through  the  inhibition  of  caspase  activity  by  S-nitrosylation 
(212;213). NO has also been implicated in the control of apoptosis depending on ATP 
levels  (214).  A  cell  study by  Leist et al  (215)  suggested that NO prevents caspase 
activation  by  inhibiting  the  mitochondrial  respiration  and  therefore  lowering  ATP 
levels.  Cell  death  is  then  delayed  but  eventually  cell  death  by  necrosis  ensues. 
However, glucose supplementation to the culture medium reverts the cells back to the 
apoptotic form. In relation to nitrergic neurones, the protection by NO by stopping the 
apoptotic cascade would potentially allow them to recover from a transient metabolic 
insult. This is particularly important in the corpus cavemosum which is subjected to 
varying degrees of hypoxia depending on the degree of tumescence. Alternatively, the
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requirement to maintain homeostasis compared to the smooth muscle cells.
4.8  Energy Sources and Compartmentalisation During Ischaemia
Smooth muscle can survive during periods of anoxia by utilising substrates in 
order to generate ATP by glycolysis.  The combination of hypoxia and glucopenia 
reduces both oxidative phosphorylation and glycolysis.  A continual supply of ATP is 
required  to  ensure  that  cellular  homeostasis  is  maintained  and  researchers  have 
proposed  that  compartmentalisation  of the  energy  sources  may  occur  in  smooth 
muscle  such  that  glycolysis  predominantly  supplies  ATP  for  cell  homeostasis  and 
oxidative  phosphorylation  supplies  ATP  for  the  contractile  machinery  (198).  My 
experiments  showed  that  in  conditions  of glucopenia,  the  reduction  in  tone  was 
progressive and reduced to the minimum level after a longer time period compared to 
when hypoxia was used alone. This suggests that impaired oxidative phosphorylation 
in hypoxic  conditions has  a greater effect on inhibiting  smooth muscle  contraction 
than the inhibition of glycolysis. The ATP utilisation by the contractile machinery is 
likely  to  be  greater  than  the  ATP  required  for  cellular  homeostasis.  During 
glucopenia,  oxygen  is  still  available  to  ensure  that  oxidative  phosphorylation 
continues by using intracellular stores of glycogen which would explain the longer 
time period for the tone to reduce in these conditions. Ultimately both conditions have 
the same effect which is a sustained minimum tone so that energy requirements are 
minimised.
In order to quantify the changes in intracellular nucleotide levels I attempted 
to  measure  the  ATP,  ADP,  AMP  and  PCr  intracellular  levels  using  high pressure
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technique proved to be unsuccessful in quantifying the changes. This may have been 
due to the very small quantity of nucleotide being present in the tissue strips which 
made it difficult to accurately achieve reproducible results after the tissue had been 
homogenised. Therefore I measured the changes in the predominant nucleotide, ATP, 
during conditions of simulated ischaemia associated with smooth muscle dysfunction 
on reperfusion.  Our results  showed a  fall  in tissue  ATP  levels  during perfusion in 
conditions of simulated ischaemia.  This fall in tissue ATP fails to recover when the 
conditions are reversed.  However, the ATP levels did not show complete depletion 
probably due to the fact that my experimental set up was not completely anoxic and it 
is  likely  that  additional  energy  substrates  from  the  degradation  of  intracellular 
organelles occurs as the duration of ischaemia increases.  The tissue ATP levels are 
still  likely to  fall  below  a critical  level  which  would  normally  be  required  for the 
maintenance of cell viability. It has been proposed that a fall in ATP levels to below 
10-15% of normal levels can induce cell death (196).
I proposed that the perfusion of cavernosal  smooth muscle  in conditions of 
hypoxia,  acidosis  and  glucopenia  combined  would  result  in  irreversible  smooth 
muscle dysfunction due to a depletion of ATP leading to cellular death. Interestingly, 
the histological  analysis  of the  corpus  cavemosum  following  4  hours  of simulated 
ischaemia  did  not  show  histological  features  consistent  with  cellular  injury.  A 
previous  study  by  Munnariz  et  al  (146)  also  analysed  corpus  cavemosum  from 
anaesthetised rabbits which was subjected to ischaemia and reperfusion. Although the 
ischaemic time was variable and not recorded in the study, 140 minutes of reperfusion 
were employed. The histological examination of tissue in this study showed adhesion
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infiltration into the underlying tissue. A study by Spycher and Hauri (143) analysed 
tissue from patients presenting with priapism of variable duration.  In this study the 
early histological  changes  (within  1 2  hours)  consisted  of minor endothelial  defects 
with occasional  lymphocyte infiltration of the trabecular tissue.  It was not until the 
priapism  episodes  extended  beyond  1 2  hours  that  intracellular  changes  in  the 
mitochondria,  endoplasmic  reticulum  and  Golgi  apparatus  became  apparent. 
Therefore there existed a paucity of histological evidence showing disruption in the 
contractile machinery of myocytes in my in vitro model which would account for the 
failure of the corpus cavemosum smooth muscle to regain its tone once the conditions 
of simulated ischaemia were reversed.
As I had already shown that intracellular ATP levels were reduced during the 
conditions of hypoxia, acidosis and glucopenia, I utilised a more sensitive technique 
in order to  verify  whether the  corpus  cavemosum  smooth  muscle  was  still  viable. 
TUNEL  staining detects DNA  fragmentation in the cell nucleus which is generally 
considered to be specific for cell death, although necrosis has been reported to cause 
‘non-apoptotic’  DNA  fragmentation.  My  experiments  using  TUNEL  staining 
confirmed the presence of significant cell death in tissue samples exposed to hypoxia, 
acidosis  and  glucopenia  for  4  hours.  This  is  the  first  study  which  has  shown 
significant  smooth  muscle  cell  death  using  TUNEL  staining  following  prolonged 
simulated  ischaemia.  Although  using  hypoxia  alone  still  resulted  in  the  smooth 
muscle cell  death, this was not as  significant as that following hypoxia,  glucopenia 
and  acidosis  combined.  However,  despite  the  presence  of  cell  death  following 
hypoxia, the tissue  strips  still managed to recover the majority of their initial tone.
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the  same  degree  of force  in  the  corpus  cavemosum.  However,  after  exposure  to 
hypoxia,  glucopenia  and  acidosis,  a  critical  level  of ATP  depletion  leading to  cell 
death is likely to occur which is no longer able to sustain smooth muscle tone. Unlike 
exposure to hypoxia alone, the loss in smooth muscle tone is partly explained by a 
reduction  in  ATP  levels  around  the  myofilaments  which  results  in  a  reduction  in 
myosin ATPase activity and subsequently MLC20 phosphorylation is reduced.
Combining these findings, I established that the presence of hypoxia, acidosis 
and glucopenia in combination results in significant metabolic inhibition of oxidative 
phosphorylation and glycolysis to such an extent that intracellular ATP levels reduce 
to  a  critical  level.  Once  these  levels  are  reached,  smooth  muscle  cell  death 
predominantly  by  apoptosis  occurs  which  eventually results  in  a failure  of smooth 
muscle contraction.
4.9  The Investigation of Patients Presenting with Low-flow Priapism
The Doppler studies performed on patients presenting with priapism recmited 
to this study have confirmed that the priapism was of a low-flow type in three of the 
seven cases;  two  patients  were  considered to have  a high-flow picture  on Doppler 
studies although clinically and on the basis of corporal blood aspirations these patients 
were in keeping with a typical low-flow priapism indicating that false positive results 
using Doppler studies can occur. The creation of an iatrogenic fistula during needle 
aspiration may account for the high-flow picture seen on Doppler studies although the 
initial  period  of  a  low-flow  priapism  would  have  already  resulted  in  significant 
smooth muscle dysfunction. Therefore Doppler studies can be misleading in making
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be taken in the interpretation of these studies.
In all our patients presenting with priapism, blood aspirates from the corpus 
cavemosum confirmed  the presence of hypoxia,  acidosis  and  glucopenia.  Although 
the presence of hypoxia and acidosis  is  in accordance with a previous  study using 
cavernosal blood aspirations (91), this study is unique in that it is the first study to 
show that glucopenia is an important parameter in those patients presenting with low- 
flow  priapism  which  fails  to  respond  to  conventional  medical  and  surgical 
management.  Whether the degree of glucopenia is significant enough to completely 
impair contractile  funciton  to  a-adrenergic  agonists  has  never been  investigated  in 
vivo as there is  a limit to the therapeutic concentration of a-agonists which can be 
injected into the human corpus cavemosum without unwanted systemic side effects 
such as  uncontrolled  hypertension.  For that  reason  I  have  studied  the  response  of 
cavernosal smooth muscle to phenylephrine ex situ.
The effect of phenylephrine on normal human corpus cavemosum showed a 
concentration-dependent  (0.1-300  pM)  increase  in  tone  with  an  E C 5 0   of  2pM. 
However,  corpus  cavemosum  from  patients  presenting  with  priapism  showed  no 
contraction to phenylephrine even at the highest concentrations (300pM). In addition 
to this, EFS did not evoke any response in the priapitic tissue but did show frequency 
dependent  relaxation  in  control  tissue.  These  results  suggest  that  the  presence  of 
hypoxia,  acidosis  and  glucopenia  during  a  priapism  episode  mediates  irreversible 
smooth muscle dysfunction.  This is in accordance with my in vitro results showing
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exposure to hypoxia, acidosis and glucopenia in combination.
Two patients had already undergone surgical intervention prior to presenting 
to  our  unit,  one  underwent  a  Winter  procedure  and  another  underwent  bilateral 
saphenocorporal  shunts  which  interestingly had  already thrombosed by the time  of 
surgery to undertake cavernosal biopsies. The formation of shunts may act solely as 
an elaborate drainage mechanism for stagnant blood over a prolonged period of time. 
Although some of the  stagnant blood in the corpus cavemosum may drain,  smooth 
muscle  dysfunction  is  likely  to  have  already  been  established  with  subsequent 
infiltration  by  inflammatory  cells  and  culminating  in  corporal  fibrosis.  TUNEL 
staining of tissue  from patients  with refractory priapism  confirmed the presence of 
widespread cell death. The long term sequel for patients such as this is that the non- 
viable  smooth  muscle  undergoes  extensive  fibrosis  leading  to  eventual  impotence 
(217). The paucity of functional smooth muscle in the corpus cavemosum means that 
erectogenic therapies such as PDE-5 inhibitors will be unsuccessful. A surgical option 
in  these  patients  would  be  to  implant  a  penile  prosthesis  albeit  with  technical 
difficulty  due  to  the  extensive  corporal  fibrosis.  Therefore,  I  propose  that  in  the 
clinical  scenario  of  prolonged  low-flow  priapism  which  is  refractory  to 
pharmacological or surgical intervention in the form of shunt surgery, an alternative 
option involves the immediate implantation of a malleable penile prosthesis. This has 
the  added  benefit  of easier  insertion  in the  absence  of corporal  fibrosis  and  lower 
morbidity.
1354.10  Critique of the study
4.10.1  Study Design
Although this study was initiated by observations in human patients presenting 
with  refractory  low-flow  priapism  who  ultimately  develop  long  term  erectile 
dysfunction, the majority of the in vitro work was conducted utilising rabbit corpus 
cavemosum.  Rabbit corpus cavemosum has been utilised extensively in the field of 
erectile dysfunction research and has been found to be a reproducible model for these 
studies. Cellek and Moncada have shown that rabbit corpus cavemosum is closer to 
human  corpus  cavemosum  compared  to  rat  and  mouse.  (218).  My  initial  work 
demonstrated  that  human  corpus  cavenosum  has  a  characteristic  concentration 
response to phenylephrine and that in the presence of hypoxia and acidosis the pattern 
of smooth muscle  relaxation was  similar to that  in rabbit  corpus  cavemosum.  The 
intracellular metabolic  pathways would be  similar in both tissues but the  stores of 
glycogen and alternative substrates is likely to be more abundant in human tissue than 
rabbit tissue due to the differential size of each species. Therefore we would expect a 
similar  phenomenon  with  human  tissue  but  probably  over  a  longer  ischaemic 
perfusion  period.  Therefore  I  can  not  directly  correlate  the  time  periods  for  the 
observed phenomenon in an  in vitro model using rabbit corpus cavemosum to that 
which may occur in human tissue.
Although  priapism  has  been  reported  in  horses  (219),  no  such  reports  of 
priapism in rabbits exists.  In our model we simulated the conditions to mimic those 
occurring  in  prolonged  low-flow  priapism  in  order  to  investigate  the  effects  on 
smooth  muscle  function.  As  the  study  used  an  in  vitro  model,  the  question  as  to 
whether the phenomenon exists in rabbits would not alter the study.
1364.10.2 Experimental protocols
One of the early noticeable features of the experimental set up was the progressive 
loss in the tone of the control tissue compared to the experimental tissue.  This was 
particularly prevalent during the prolonged 48 hour experiments which showed that 
by 24 hours, the control tissue had completely lost all of its initial tone. The tissue 
subjected to hypoxia demonstrated that although the tone was significantly reduced, 
there was still a degree of recovery of tone following reperfusion. The loss in tone of 
the control tissue may be a result of oxidative stress. The continuous gassing of the 
Krebs solution with 95% O2 would result in the generation of free radicals leading to 
oxidative  smooth muscle  cell  injury.  Normal  corpus cavemosum would function at 
between 25mmHg to  lOOmmHg whereas 95% O2 was measured to be equivalent to 
lOOmmHg in both the chamber and organ bath. Tissue strips which were exposed to 
hypoxic conditions may sense the reduction in pC>2 and undergo a degree of cellular 
shutdown. This in itself may offer cytoprotection to further oxidative insults.
4.10.3 Metabolic studies
Experiments  which  used  a  combination  of  hypoxia  and  glucopenia  to 
reproduce  conditions  of  metabolic  inhibition  showed  irreversible  smooth  muscle 
dysfunction.  I  then  attempted  to  reproduce  these  pharmacologically  by  using 
iodoacetic  acid  to  inhibit  glycolysis  and  myxothiazol  to  inhibit  cytochrome  c  and 
therefore oxidative phosphorylation.  Iodoacetic acid rapidly reduced the tone of the 
precontracted tissue strips.  However, iodoacetic acid is a sulfhydryl reagent causing 
irreversible  damage  to  glycerol  phosphate  dehydrogenase  and  therefore  my 
experiments which investigated the reversal of hypoxia and glucopenia could not be 
reproduced. The loss in tone was much more rapid which indicates that both glucose
137and glycogen metabolism is inhibited as opposed to when glucopenia is used whence 
glycogen  metabolism  can  still  continue  intracellularly  and the  reduction  in tone  is 
much  slower.  Addition  of myxothiazol  which  is  a  potent  cytochrome  c  inhibitor 
resulted in a much slower reduction in the tone. Although initially it was difficult to 
explain  this  phenomenon,  it  may  be  due  to  myxothiazol  having  poor  tissue 
penetration.  Reviewing  the  previous  work  which  has  been  performed  using  this 
compound, most studies have been performed on cell cultures and therefore it may be 
more  appropriate  for  cell  based  experiments  (220).  Experiments  could  have  been 
repeated using cyanide which is  also  an inhibitor of cytochrome c but these would 
reproduce the conditions of total anoxia when we know that complete anoxia does not 
occur in the corporal microenvironment. By using a mixture of 95% N2 and 5% CO2, 
total anoxia does not occur in this set up due to the equilibration through the apparatus 
tubings, reservoir etc and this is more representative of the hypoxia which occurs in 
the corpus cavemosum in vivo.
Tissue strips were not weighed as per protocols described elsewhere (8 8 ). As 
each experiment analysed the results as a ratio of the initial tone, variability would be 
based on an alteration in conditions within the same experimental protocol. Inter-strip 
variation  was  reduced  by  using  the  same  experimental  set  up  and  gas  supply 
throughout  all  the  experiments.  For  each  experiment  two  tissues  strips  would  be 
superfused by solutions from the same organ bath.
Although the TUNEL staining experiments performed on tissue strips exposed 
to hypoxia showed that there was no significant increase in TUNEL positive nuclei, I 
used  this  finding  to  explain  the  almost  complete  recovery  of smooth  muscle  tone
138when hypoxia was reversed. However, measurement of the tissue ATP levels in this 
tissue would also have been useful in order to analyse the change in the ATP levels 
during these particular experiments and correlate the results to changes in the TUNEL 
staining of the same tissue.
4.11  Future developments
Organ  bath  studies  have  allowed  the  establishment  of a  basic  model  and 
allowed us to formulate a possible sequence of events which occur during prolonged 
priapism. During the development of the study, it was noted that Ca2+ measurements 
using FURA 2 loaded tissue have been conducted elsewhere (8 8 ). Although previous 
studies investigating the effects of hypoxia on corporal smooth muscle have shown an 
elevation  in  the  intracellular  Ca2+  levels  (8 8 )  subsequent  experiments  showed  a 
reduction in the intracellular Ca2+  following exposure to acidosis (151). The effects 
of glucopenia  on  intracellular  Ca2+  have  yet  to  be  established.  In  conditions  of
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hypoxia, acidosis and glucopenia, it is uncertain as to whether the overall Ca  will 
increase, decrease or remain unaltered. As mentioned in this discussion, the effects of 
hypoxia on intracellular Ca2+ levels using a variety of tissue remains variable. FURA2 
loading techniques in tissue are not the optimum technique to ascertain transient Ca2+ 
fluxes.  A  better  model  to  develop  is  one  of isolated  corpus  cavemosum  cells  and 
utilise the technique to measure the Ca2+  transients in conditions of acidosis, hypoxia 
and glucopenia on the isolated cells. By depleting sarcoplasmic stores of Ca2+ using 
compounds such as caffeine and selectively inhibiting L-Type voltage gated channels 
using glibenclamide, we can investigate the effects of ischaemia on Ca2+ mobilisation 
from  extracellular and  intracellular  stores.  This  would  aid  our understanding  as  to
1392“^"  •  • whether  Ca  transients  in  the  corpus  cavemosum  are  predominantly  due  to 
mobilization of intra or extracellular sources.
My  experiments  using  putative  agents  failed  to  prevent  irreversible  smooth 
muscle  dysfunction.  However,  a  number  of  potential  agents  could  still  have  a 
potential role in preventing smooth muscle dysfunction. Possible additional agents to 
those already mentioned include adenosine triphosphate -MgCl as we know that ATP 
depletion  occurs  during  the  period  of simulated  ischaemia.  This  compound  would 
provide an additional source of energy synthesis.
Finally, the effects of ischaemia and reperfusion on corpus cavemosum could 
be  further quantified  biochemically by  measuring the  amount  of lipid peroxidation 
and myeloperoxidase activity in the corpus cavemosum. This could be performed by 
homogenising  the  tissue  following  ischaemia  and  reperfusion  or  by  collecting  the 
superfusate at timed intervals in order to establish whether this is a time dependent 
phenomenon.
4.12  Conclusion
Although the incidence of low-flow priapism is rare in the general population, 
the paucity  of research  into  this  condition has  led  to  both  uncertainty  and limited 
therapeutic  options  in  the  management  of  this  condition.  Currently  the  surgical 
management has been based on case series of differing corporal drainage operations. 
The  pharmacological  management  using  a-adrenergic  agonists  does  have  a  solid 
scientific foundation but is not always successful. The long term outcome for patients 
failing these treatment options is the development of corporal fibrosis and ultimately
140erectile dysfunction which is devastating for young men of reproductive age groups. 
The  aim  of  this  thesis  was  to  gain  a  better  understanding  of  the  underlying 
pathophysiology  mediating  refractory  low-flow  priapism.  I  hypothesised  that  the 
exposure  of the  corpus  cavemosum  to  prolonged hypoxia or  acidosis  alone would 
result in irreversible smooth muscle dysfunction. However, this was disproved. Using 
my findings from clinical patients, I found that the predominant factors mediating the 
irreversible  dysfunction  were  hypoxia and  glucopenia  in  combination.  When these 
two parameters coexist, significant ATP depletion in the corpus cavemosum smooth 
muscle  cells  results  in  cellular  death  which  eventually  manifests  as  irreversible 
smooth muscle dysfunction.
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Patients Information sheet and consent formUniversity College London Hospitals
NHS Trust
Patient Information Sheet - CONFIDENTIAL
Investigators : Mr D J Ralph (Principal), Mr A Muneer, Mr S Minhas
Version: 3 
Date: 11/7/03 
Project ID:03/0158
E rectile Dysfunction in Priapism
Prospective tissue
You are being invited to take part in a research study.  Before you decide it is important for you 
to understand why the research is being done and what it will involve.  Please take time to read 
the following information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to decide whether 
or not you wish to take part.
What is the purpose of the study?
We  are  conducting  the  above  study  in  order  to  investigate  why  men  presenting  with  prolonged 
erections (priapism) fail to respond to treatment.
Why have I been chosen?
As this condition is rare, you have been chosen because you are one of the few patients that we have 
seen with this condition.
Do I have to take part?
It is up to you to decide whether or not to take part.  If you do decide to take part  you will be given 
this information sheet to keep and be asked to sign a consent form.  If you decide to take part you are 
still free to withdraw at any time and without giving a reason.  A decision to withdraw at any time, or 
a decision not to take part, will not affect the standard of care you receive.
What is involved in the study  ?
Your decision to take part in the study will allow our investigators to analyse tissue specimens which 
were  taken  as  a  biopsy  before  you  have  a  penile  prosthesis  inserted.  The  data  collected  will  be 
anonymous  and  collected  by  the  Investigators  above.  We  will  analyse  the  tissue  to  see  whether 
specific features exist in all  the  similar cases  like  yours.  This will  help to  define  future treatment 
options in this condition.University College London Hospitals
NHS Trust
What are the possible benefits of taking nart?
Although there  is  no  intended  clinical  benefit  to  yourself,  the  study  will  help  to  understand  this 
condition more fully.
What information will be held?
All the information collected will be strictly confidential. The tissue samples will be coded so that 
your details are not passed on or stored in any way. We will use information such as the duration of 
your erection before your operation and the treatment given before the insertion of the penile implant. 
All the data will be collected, handled and stored at UC1 and UCLH.
What happens to your tissue?
You should be aware that the tissue samples are being donated as a gift and may be used for future 
research. Any future research will be reviewed by the ethics committee.
What will happen to the results of the research study?
The results of the study will be published in a reputable urology journal.
Who is organising and funding the research?
The costs involved in the study to analyse the tissue will be paid by our own St Peters Andrology 
Fund.
Who has reviewed the study?
The study has been reviewed by the UCLH ethics committee.
Contact for further information
For further information please contact Mr A Muneer, Research Fellow Tel  .
You will be given one copy of this information sheet and a signed consent form.University College London Hospitals
NHS Trust
CONFIDENTIAL
UCLH Project ID number: 03/0158 
Form version: 1.5/03
CONSENT FORM
Title of project: Corporal Smooth Muscle Dysfunction in Ischaemic Priapism
Principal investigator: Mr D J Ralph. 
Additional Investigators : Mr A Muneer, Mr S Minhas 
Department of Urology, Institute of Urology and Nephrology, UCLH
1.  I confirm that I have read and understood the information sheet dated 
11/7/03 (version 3.) for the above study and have had the opportunity to 
ask questions.
2.  1 confirm that 1 have had sufficient time to consider whether or not 1 
would like to have my tissue samples included in the study
3.  I understand that my  participation is voluntary and that I  am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.
4.  I understand that sections of my medical notes will only be looked at by 
the investigators named above.
5.  I  give  permission  to  allow  my  tissue  samples  to  be  used  in  the  above 
study and I understand that they are being donated as a gift and may be 
used for future research in this Department.
Centre Number: 
Patient Identification Number:University College London Hospitals
NHS Trust
Centre Number:  UCLH Project ID number: 03/0158
Patient Identification Number for this study:  Form version:  1
CONSENT FORM - CONFIDENTIAL
Title of project: Corporal Smooth Muscle Dysfunction in Ischaemic Priapism
Name of Principal investigator: Mr D J Ralph
Name of patient  Date  Signature
Name of Person taking consent  Date  Signature
Mr A Muneer 
Researcher (to be contacted 
if there are any problems)
Comments or concerns during the study
If you have any comments or concerns you may discuss these with 
the investigator.  If you wish to go further and complain about any 
aspect of the way you have been approached or treated during the 
course of the study, you should write or get in touch with the 
Complaints Manager, UCL hospitals.  Please quote the UCLH project 
number at the top this consent form.
1 form for Patient;
1 to be kept as part of the study documentation, 
1 to be kept with hospital notes